Time until first analgesic requirement, post caesarean section under spinal anaesthesia, in HIV-positive patients at Chris Hani Baragwanath Hospital by Wagner, Janine Louise
i 
 
 
Time until first analgesic requirement, post caesarean section under 
spinal anaesthesia, in HIV-positive patients at Chris Hani 
Baragwanath Hospital. 
 
Janine Louise Wagner 
 
 
 
 
 
 
A research report submitted to the Faculty of Health Sciences, University of the 
Witwatersrand, Johannesbutg, in partial fulfilment of the requirements for the degree of 
Masters of Medicine in the branch of Anaesthesia 
 
 
Johannesburg 2010 
ii 
 
DECLARATION 
 
I, Janine Louise Wagner, declare that this research report is my own work. It is being 
submitted for the degree of Master of Medicine in the branch of Anaesthesia at the 
University of the Witwatersrand, Johannesburg. It has not been submitted before for any 
degree or examination at this or any other University. 
 
 
 
 
 
 
 
JL Wagner 
Signature 
 
8 
th
 of April, 2011 
 
 
 
iii 
 
    For those who strive to improve the lives of others. 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
PRESENTATIONS ARISING FROM THIS STUDY 
Presented as a poster at the South Africa Society of Anaesthesiologists (SASA) congress, 
Bloemfontein, March 2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
PREFACE 
During the first year of my training in anaesthesia, I had an impression that many of my 
HIV- positive patients were requiring greater doses of analgesics intraoperatively. A 
proportion of my patients were experiencing short durations of analgesia from spinal 
anaesthetics and were requiring additional analgesia in the recovery room. I had been 
trained only to perform spinal anaesthetics with 0.5 % heavy bupivacaine and had 
reservations towards the use of intrathecal opioids, due to fears that my patients would 
experience postoperative respiratory depression or even apnoea, which would go unnoticed 
in the extremely busy postoperative recovery wards. With this in mind, I approached the 
senior Obstetric Anaesthetist, who would later become both my mentor and supervisor, and 
shared with her my perhaps biased observations. Thus came about the topic for my 
research project. 
I am greatly indebted to Dr Phillipa Penfold for her continuous encouragement, advice, 
guidance, constructive criticism and support.  Not only has she been an integral part of this 
research project from the development of the topic, but her knowledge and expertise have 
led to a vast improvement and insight into my own Obstetric Anaesthetic practice.  
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ABSTRACT 
BACKGROUND 
Multiple studies have been conducted comparing the efficacy and duration of analgesia 
obtained from spinal anaesthesia containing local anaesthetics as well as opioids. The 
literature available has not considered the individual‟s HIV status as a variable. 
Postoperative analgesic duration and requirements in this group of patients may differ due 
to the occurrence of acute and chronic pain syndromes, pain arising from the disease itself, 
side effects of treatment for HIV infection, or opportunistic infections. Response to opioid 
analgesia may be altered due to previous opioid exposure, potential increase in 
nociception, drug interactions and emotional status.  
OBJECTIVES 
The primary objective of this study was to determine the time to post-operative analgesic 
request in HIV-positive and negative individuals having caesarean sections under spinal 
anaesthesia containing bupivacaine or bupivacaine and fentanyl. The secondary objectives 
of this study were to determine if factors such as height, ethnicity, level of education, CD4 
count, and antiretroviral therapy impacted on the duration of analgesia obtained. 
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METHOD 
In consultation with a statistician it was decided that a minimum of 56 HIV-positive and 56 
HIV-negative patients would be required to determine if a statistically significant 
difference in duration of analgesia existed between the HIV-positive and negative 
individuals. The sample size was calculated assuming that a difference of 20 minutes 
existed between these patients, with a standard deviation of 35 and a power of 85%, with 
the significance level set at p <0.05. 30 patients in each of the four subgroups would be 
required to achieve a power of 100% with standard deviation of 35 and alpha value of 0.05 
when analysed by an ANOVA test. The four subgroups studied were: HIV-positive 
bupivacaine (HPB), HIV-positive bupivacaine and fentanyl (HPBF), HIV-negative 
bupivacaine (HNB) and HIV-negative bupivacaine and fentanyl (HNBF) 
It was thus decided that the study should consist of total sample size of 120 individuals; 60 
HIV-positive and 60 HIV-negative. 30 patients in each group would receive 2ml 0,5 % 
heavy bupivacaine and 0,4ml normal saline and 30 would receive 2ml 0,5 % heavy 
bupivacaine and 0,4 ml fentanyl (20ug).   
Intrathecal drugs were administered in a double-blinded fashion utilising pre-mixed coded 
syringes and a standardised spinal technique was employed.  
Time of administration of anaesthetic was noted and patients were monitored at 30 minute 
intervals thereafter until analgesia was requested. A visual analogue pain score was utilised 
to monitor the patient‟s pain. 
Once patients requested analgesia nursing staff were informed and analgesia given 
according to ward protocol.         
  
viii 
 
RESULTS 
The data collected showed that the addition of fentanyl to the intrathecal injection 
significantly prolongs the duration of analgesia by a range of 25-80 minutes. It was 
determined that HIV infection, CD 4 count, antiretroviral therapy, height, ethnicity, and 
level of education did not significantly alter the duration of analgesia obtained from 
intrathecal injection. 
CONCLUSION 
Intrathecal anaesthesia provides limited postoperative analgesia. HIV infection itself has 
no effect on the duration of analgesia obtained. The addition of 20 ug fentanyl to 
hyperbaric bupivacaine significantly prolongs the duration of analgesia in the post-surgical 
care unit. 
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CHAPTER ONE – INTRODUCTION 
1.1 Introduction 
Multiple studies have been conducted comparing the efficacy and duration of analgesia 
obtained from spinal anaesthesia, containing local anaesthetics and opioids. The duration 
of post-operative pain relief and time to first analgesic request following spinal anaesthesia  
ranges from 90 to 190  minutes for intrathecal bupivacaine alone and up to 184 (+/- 20) 
minutes for intrathecal fentanyl and bupivacaine 
1-13
. 
Most of these studies have been conducted in the developed world in populations where 
the prevalence Human Immunodeficiency Virus (HIV) infection is known to be low 
14
 . 
Between 523 and 706 caesarean sections are performed monthly at Chris Hani 
Baragwanath Hospital (CHBH) 
15
.
 
 The prevalence of HIV-infection in these obstetrics 
patients ranges from 30-35% and voluntary counselling and testing rates in the antenatal 
clinic are as high as 90%. Intrathecal opioid administration is often avoided or limited to 
low doses due to the fear of inadequate monitoring for post-operative respiratory 
depression. The high turnover of patients, overloaded post-caesarean section ward, and 
limited nursing staff available to nurse patients has led to standardised provision of post-
operative analgesia, which may be inadequate for many patients. 
Inadequate postoperative pain control can have a severe impact on both the mother and 
infant, and numerous deleterious effects of post-operative pain in obstetric patients are well 
described 
16
.
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Estimates of the prevalence of pain in patients with HIV/AIDS range from 40%-93%. 
Despite the high frequency of pain in these patients, pain relief is often overlooked and 
there is no literature available concerning duration of postoperative analgesia obtained 
from intrathecal anaesthesia. Postoperative analgesic duration and requirements in HIV- 
positive patients may differ as multi-faceted pain as well as acute and chronic pain 
syndromes are commonly encountered. HIV- positive individuals often have pain arising 
from multiple aetiologies occurring concurrently due to various aspects of the disease 
itself, side effects of treatment for HIV infection, opportunistic infections e.g. 
cytomegalovirus, neuropathies due to nutritional deficiency, critical illness neuropathy, and 
cytokine-mediated neurotoxic effects 
17-23
 . Response to opioid analgesia may be altered 
due to previous opioid exposure, potential increase in nociception, drug interactions and 
emotional status 
17-23
. Although opiate-resistant pain has been described in HIV/AIDS 
patients, it is not a common finding 
23
. It may be possible that HIV infection will alter the 
duration of postoperative analgesia obtained from intrathecal anaesthesia.   
  
 
1.2  Problem statement 
The duration of analgesia obtained from caesarean sections under spinal anaesthesia in 
HIV- positive patients is unknown and may differ from that achieved in HIV- negative 
patients. 
1.3 Aim 
The aim of the study was to determine if HIV- positive patients having caesarean sections 
under spinal anaesthesia containing bupivacaine or bupivacaine and fentanyl had differing 
durations of analgesia to HIV- negative patients. 
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The null hypothesis of the study is that there is a no difference in the duration of analgesia 
obtained from spinal anaesthesia, containing bupivacaine or bupivacaine and fentanyl, in 
HIV-positive patients compared to HIV-negative patients. 
The alternative hypothesis is that there is a difference in the duration of analgesia 
obtained from spinal anaesthesia, containing bupivacaine or bupivacaine and fentanyl, in 
HIV-positive patients compared to HIV-negative patients. 
     
1.4  Objectives 
The primary objective of this study was to determine whether there was a difference in the 
time to first post-operative analgesic request in HIV- positive and negative patients after 
having undergone a caesarean section, under spinal anaesthesia, containing bupivacaine or 
bupivacaine and fentanyl.  
The secondary objectives of this study were to determine if factors such as height, 
ethnicity, level of education, CD4 count, and antiretroviral therapy impacted on the 
duration of analgesia obtained. 
 
1.5  Research assumptions 
 
1.6  Study design 
This study is a prospective, randomised, quantitative double-blinded observational study. 
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1.7  Ethical considerations 
 
1.7.1 Ethical clearance 
The study has been approved by the regional Ethics Committee – the committee for 
research on Human Subjects (Medical) of the University of the Witwatersrand (Appendix 
A).           
1.7.2 Post-Graduate approval 
The study has been approved by the Post-Graduate Committee of the University of the 
Witwatersrand, Faculty of Health Sciences (Appendix B) 
1.7.3 Site approval 
Permission to complete this research project, collect data (including HIV status) from 
patient‟s files and to interview patients has been granted by the Clinical Director of CHBH. 
(Appendix C). 
1.7.4 Patient consent 
Patients were invited to participate in the study. Patients received a printed document 
(Appendix D) explaining the reason for the study, exactly what their involvement in the 
study would be, their right to refuse to participate without repercussions to their care, and 
their right to withdraw from the study at any time. A 24-hour contact number was supplied 
should they have required further information. The printed information was provided in 
English. The researcher and a translator provided verbal information in a language that the 
patient could understand if they could not understand English, or were not able to read the 
document. Written consent was obtained from all patients agreeing to participate 
(Appendix E).  
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1.7.5 Declaration of Helsinki 
The research was conducted according to the principles described in the Declaration of 
Helsinki 
25
 .            
1.8   Summary of methodology 
After permission from the relevant authorities was granted, participants were identified in 
the labour ward or in labour admissions ward. Participants matching the inclusion criteria 
were approached for inclusion into the study.   
Written informed consent was obtained preoperatively from patients without exclusion 
criteria. The patients were made aware that their participation was voluntary and that their 
results would be analysed by means of a numerical code system. All information that 
would link their identity to the trial results would remain separate and confidential. 
Use of medically knowledgeable translators was made if a language barrier was 
encountered or if the patient requested that the information and consent forms be explained 
to them in a language of their choice. Translation was provided by a team of anaesthetic 
trained nursing sisters who worked in the obstetric theatres. 
In consultation with a statistician it was decided that a minimum of 56 HIV-positive and 56 
HIV-negative patients would be required to determine if a statistically significant 
difference in duration of analgesia existed between the HIV-positive and negative 
individuals.  
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The sample size was calculated assuming that a difference of 20 minutes existed between 
these patients, with a standard deviation of 35 and a power of 85%, with the significance 
level set at p <0.05. 30 patients in each of the four subgroup: HIV-positive bupivacaine 
(HPB), HIV-positive bupivacaine and fentanyl (HPBF), HIV-negative bupivacaine (HNB) 
and HIV-negative bupivacaine and fentanyl (HNBF) would be required to achieve a power 
of 100% with standard deviation of 35 and alpha value of 0.05 when analysed by an 
ANOVA 1- way test (assuming a normal distribution).  
The study consisted of total sample size of 120 individuals. 30 HIV-positive patients 
received intrathecal bupivacaine alone (HPB) and a control group of 30 HIV-negative 
patients received the same treatment (HNB); 30 HIV-positive patients received intrathecal 
bupivacaine and fentanyl (HPBF) and a control group of 30 HIV-negative patients received 
the same treatment (HNBF). A schematic representation of the research groups is shown in 
Figure 1.1. 
Information was collected from the patient interviews as well as the patients‟ hospital files 
and antenatal records. The information collected included height, weight, age, ethnicity, 
education, HIV status, CD4 count, and whether the patient was receiving antiretroviral 
therapy.  
Intrathecal drugs were administered in a double-blinded fashion utilising pre-mixed coded 
syringes and a standardised spinal technique was employed. Spinal anaesthetic options 
included 2ml 0,5 % heavy bupivacaine and 0,4ml normal saline or 2ml 0,5 % heavy 
bupivacaine and 0,4 ml fentanyl (20ug). 
Time of administration of anaesthetic was noted and patients were monitored at 30 minute 
interval thereafter until analgesia was requested. Visual analogue pain score was utilised to 
monitor the patients‟ pain. Figure 1.2 depicts the visual analogue scales utilised. 
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Figure 1.2  Visual analogue scale utilised 
22 26
 . 
Elective c/s pts
(120) 
HIV- positive pts
(Study group)
(60)
Spinal anaesthetic with 
bupivacaine
(30)
Spinal anaesthetic with 
bupivacaine and fentanyl
(30)
HIV- negative pts
(control group)
(60)
Spinal anaesthetic with 
bupivacaine
(30)
Spinal anaesthetic with 
bupivacaine and fentanyl
(30)
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Postoperative analgesia was prescribed according to the ward protocol which included 
Omnopon ® (morphine hydrochloride, papaverine hydrochloride, and codeine 
hydrochloride) and paracetamol. As soon as the patients requested analgesia the ward 
nursing staff were notified and requested to administer the prescription.  
The study ended when there were 30 HIV-positive individuals who have received 
intrathecal bupivacaine with 30 HIV-negative individuals as a control group and 30 HIV-
positive individuals who have received intrathecal bupivacaine and fentanyl with 30  HIV-
negative individuals as a control group.  
1.9   Significance of the study 
The significance of the study will be discussed below. 
1.9.1   The results of the study may be able to guide anaesthetists in the possible benefits 
of varying spinal mixtures. 
1.9.2.   The study results may provide a rough estimate as to when additional analgesics 
can be expected to be necessary and thus aid in the better provision of postoperative 
analgesia to post caesarean section patients at CHBH.  
1.9.3   The study may encourage others to pursue the improvement of postoperative pain   
provision in our hospitals with possible development of postoperative pain teams.  
1.9.4  The results of the study may direct further research in the field of providing 
analgesia in the HIV-positive parturient.                 
1.9.6  The results of the study might demonstrate that factors such a height, ethnicity, and 
education may alter the duration of analgesia obtained from spinal anaesthesia.  
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1.9.7 The results of this study, by defining an expected duration of analgesia, may alert 
the anaesthetist to early identification of a complicated prolonged block. This may 
lead to early intervention and possibly a better patient outcome. 
1.10   Study limitations 
1.10.1  Study period: 
The data collection was done over a 6 month period from June to November 2008. The 
data was collected predominantly in November 2008. The data was collected when it was 
convenient for the investigator to do so.  
This convenient data collection led to a non-continuous selection of patients. This will be 
mentioned further in the discussion. 
1.10.2  Frequent delays and postponement of elective patients: 
Only two Obstetric theatres are available at CHBH. Emergency caesarean sections take 
precedence over elective cases. Patients are frequently repeatedly delayed and postponed. 
This repeated delay may cause increased patient anxiety which may affect the results 
obtained. This will be discussed further in chapter 5. 
1.10.3  Surgeon variations: 
Although caesarean sections are performed using a standardised technique taught at 
CHBH, the caesarean sections were performed by various different surgeons, with 
differing levels of experience, differing surgical durations, differing degrees of tissue 
trauma and blood loss. The impact that this may have will be discussed in chapter 5. 
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1.10.4  Contextuality: 
This study was done in the context of patients presenting for elective caesarean section at 
CHBH. Generalisation to other populations may be limited. 
1.10.5   Retrospective review of data: 
Data collected from the antenatal card was collected retrospectively, as with all 
retrospectively collected data, the quality of the data collected is dependent on the quality 
of record keeping. In parturients, while antenatal cards are often filled in thoroughly, there 
are sometimes gaps in the available information. 
1.11   Research report outline   
This research report will comprise the following chapters: 
 
Chapter One: an introduction to the study, including the aim and objectives 
of the study, and a brief summary of the methodology used. 
 
Chapter Two:  a review of the literature pertinent to topics raised by the 
study. 
 
Chapter Three:   an in-depth description of the methodology used for the 
study. 
 
Chapter Four:   the results of the study 
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Chapter Five: an interpretation of the results of the study, and a discussion 
of the issues raised by the results. 
 
Chapter Six:  a summary of the study, and conclusions drawn from the 
study. 
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CHAPTER 2 – LITERATURE REVIEW   
In this chapter we will include a review of the literature pertinent to topics raised by the 
study. We will discuss the caesarean section, pain arising from the caesarean section, 
anaesthesia for caesarean sections, the spinal anaesthetic, mechanism of action of local 
anaesthetics and opiates used in spinal anaesthetics, the definitions of pain, mechanisms of 
pain in HIV, HIV and AIDS and antiretroviral therapy. 
2.1   Introduction    
Severe postoperative pain results in unnecessary suffering and potentially severe 
complications that affect both the mother and infant 
16
. Caesarean sections are often 
associated with severe postoperative pain from the surgical procedure itself, as well as 
complications of the anaesthetic provided 
16 26 27
.  
In modern anaesthetic practice the prevention of intraoperative pain continues to expand to 
encompass postoperative care, as well as the treatment and prevention of acute and chronic 
pain syndromes 
28-33
. Postoperative pain continues to be a huge burden in our clinical 
setting, even though there are numerous simple and cheap methods of monitoring and 
recording postoperative pain. The high turnover of patients, overloaded post-caesarean 
section wards, lack of monitoring facilities, and limited nursing staff (who are often the 
sole providers of postoperative analgesia and pain monitoring) has led to standardised 
provision of post-operative analgesia, which may be inadequate for many patients.  
The knowledge and skills possessed by anaesthetists, to manage postoperative pain 
continues to be underutilised 
26 32
.  
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Pain has been characterized as the most significant disability in people living with 
HIV/AIDS. Estimates of the prevalence of pain in patients with HIV/AIDS range from 
40%-93%  
17-20 34.
  
Despite the high frequency of pain in these patients, and the increased risk of developing 
complications and chronic pain syndromes, postoperative pain management is still often 
inadequate. 
Between 523 and 706 caesarean sections are performed monthly at CHBH
15
. Spinal 
anaesthesia has become the most common and preferred method to provide analgesia 
during the caesarean section 
35-37
. The analgesia obtained from spinal anaesthesia, although 
ideal for intraoperative pain relief, is often short-lived and inadequate to manage 
postoperative pain. Multiple studies have been conducted comparing the efficacy and 
duration of analgesia obtained from various preparations of spinal anaesthetics 
1-12 38
. 
Numerous studies have shown that the addition of fentanyl to spinal anaesthetics prolongs 
the duration of analgesia and improves the quality of the anaesthetic provided 
1-12 38
.  
Intrathecal opioid administration in our clinical setting is often avoided, or limited to low 
doses of short acting drugs, due to the fear of inadequate monitoring for post-operative 
respiratory depression.  
It is estimated that more than 42 million people are living with HIV/AIDS, 58% are 
female, and almost 70% of whom live in sub-Saharan Africa
39-40
. The prevalence of HIV-
infection in obstetric patients in sub-Saharan Africa is estimated to range from 25-35% 
39 
41
. There is currently no literature available that describes the duration of postoperative 
analgesia obtained from spinal anaesthesia in HIV positive patients. 
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2.2  The caesarean section  
2.2.1  History 
The caesarean section is one of the most commonly performed major operations 
throughout the world 
42
.  Caesarean section rates as high as 25-50 % of all maternal 
deliveries are encountered in many countries and vertical transmission rates, in the absence 
of the use of antiretroviral drugs, as high as 80 % have been reported in some private sector 
hospitals 
43-44
.  
The caesarean section has been part of human culture since ancient times. Numerous 
references to the caesarean section appear in ancient Hindu, Egyptian, Grecian, Roman, 
and other European folklore. The origin of the term "caesarean” has been distorted over 
time. It is commonly and inaccurately believed to be derived from the surgical birth of 
Julius Caesar. Ultimately, though, we cannot be sure of where or when the term caesarean 
was derived 
 47
. 
2.2.2.  Relevant anatomy and surgical technique  
 
Pain occurring during the performance of a caesarean section comprises both visceral as 
well as somatic components. Pain originates from the Pfannenstiel / infraumbilical skin 
incision, stretching of the skin and muscles, intraperitoneal manipulation, incision and 
traction of visceral and parietal peritoneum, bladder and uterus as well as secondary to 
diaphragmatic stimulation. The cutaneous nerve supply arises from the anterior rami of the 
lower thoracic and lumbar spinal roots. The major nerves supplying the anterior abdominal 
wall are the iliohypogastric nerve (L1), ilioinguinal nerve (L1), subcostal nerves (T12) and 
intercostals nerves (T7-11). The Pfannenstiel / infraumbilical incision necessitates 
blockade of T11 to L1 dermatomes 
45-46
.  
15 
 
Stretching of the skin may require two to four levels higher. The pelvic organs derive their 
sensory innervations from both sympathetic and parasympathetic nerves. Parasympathetic 
nerves play a secondary role compared with the sympathetic nerve supply. Most pelvic 
viscera derive their supply from the coeliac and superior hypogastric plexuses. It is 
therefore necessary to achieve blockade to a dermatomal level of T6 to ensure adequate 
intraoperative analgesia 
45-46
. 
 
2.2.2.1  The Skin Incision  
The choice of skin incision is based on surgeon and patient preferences as well as delivery 
indication and difficulty anticipated. A low transverse incision of approximately 15cm is 
usually chosen because of its cosmetic appeal and lesser chance of incisional herniation or 
wound dehiscence. Alternatively, a low vertical incision may be chosen as it allows for 
quick access to the lower uterine segment, better exposure, less blood loss and easier 
access to the upper abdomen. The Pfannenstiel transverse skin incision is most commonly 
used incision. The Joel-Cohen incision is positioned higher, is straight rather than slightly 
curved and the peritoneum is opened transversely rather than longitudinally. Another 
alternative is the Maylard incision which requires more dissection and is associated with 
greater post-operative discomfort. Incisions may be greater than 15cm if a difficult 
delivery is anticipated 
49-50
.  
 
2.2.2.2  Separation of the abdominal muscles 
Traction is applied by the surgeon and the assistant to separate the rectus abdominal 
muscles.  
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2.2.2.3  The Uterine Incision 
Having carefully opened the abdomen the surgeon exposes the lower segment of the 
uterus. The visceral peritoneum is incised and the bladder is pushed down. Approximately 
90 percent of all uterine incisions are made in the low transverse rather than vertical 
direction the uterus is opened slowly and when the bulge of membranes appears it is 
pricked or torn with a forceps and the amniotic sac is opened fully with a finger from each 
side 
49-50
.  
2.2.2.4  Delivery of the foetus and placenta 
In most circumstances delivery of the foetal head is easy with sufficient fundal pressure.  
 2.2.2.5  Uterine and Abdominal closure 
Uterine and Abdominal closure is completed by continuous running suturing of the uterine, 
fascial and skin layers to ensure preservation of original blood supply with minimal injury 
49-50
.  
Exteriorization and traction of the uterus is commonly practised at Chris Hani 
Baragwanath Hospital (CHBH). It is used to decrease blood loss and facilitate suturing but 
exteriorization has been associated with patients complaining of pain and nausea as well as 
an increase in the incidence of venous air embolism 
49-50
.  
The visceral and parietal peritoneum is either closed or left open. Non-closure of the 
peritoneum is the most commonly performed technique performed and is the technique 
commonly practised by surgeons at CHBH. Non-closure may carry some short-term 
advantages including lower risk of postoperative infection, shorter operating time and 
shorter hospital stay. The operating time is slightly shorter (approximately 8 minutes) if the 
parietal peritoneum is left open and these patients are also known to require fewer doses of 
postoperative analgesics and to develop fewer adhesions 
49-50
. 
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Closure of the fascia is commonly performed in a standard single layer manner using 
synthetic suture
49-50
.     
2.2.3  Anaesthesia for caesarean sections  
Spinal and epidural anaesthetics are now the most popular choices for elective caesarean 
sections; spinal anaesthesia is now being used in more than 90% of cases in certain 
hospitals 
36-37
 . At CHBH approximately 10-15 % of caesarean sections are performed 
under general anaesthesia 
15
.
 
Regional techniques possibly have several advantages, namely avoiding a potentially 
difficult airway, decreased risk of gastric aspiration, the avoidance of depressant 
anaesthetic drugs and neuromuscular blockers, decreased drug delivery to the infant, and 
allowing the mother to be awake during the delivery. General anaesthesia is associated 
with an increased risk of gastric aspiration and morbidity associated with an inability to 
secure the airway 
52 53
. 
The mortality rate with general anaesthesia is 16.7 times greater than that with regional 
anaesthesia. The newborn‟s outcome is similar after caesarean section under regional or 
general anaesthesia 
36-37
. 
The height of the block must extend to at least the T4-T6 dermatome in order to provide 
adequate intraoperative anaesthesia 
52 53
.  
In elective caesarean sections, the duration of antepartum anaesthesia does not seem to 
affect neonatal outcome so long as hypotension is treated promptly and protracted 
aortocaval compression is avoided 
54
. 
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Spinal (subarachnoid/ intrathecal) anaesthesia is the most commonly administered 
anaesthetic due its speed of onset and reliability. The advantages of the technique include a 
rapid onset, good quality block, with an acceptably low failure rate of approximately      
1.3 %.  Local anaesthetic overdose or inadvertent intravascular or intrathecal injection of a 
large dose of local anaesthetic, as can occur with epidural or spinal anaesthesia, can be 
avoided if spinal anaesthesia is used as small amounts of local anaesthetic are given
52 53 
55
.The faster onset of the block results in an arguably shorter turn-over time and possible 
cost savings. 
In our clinical setting at CHBH spinal anaesthesia is the technique of choice as onset of 
anaesthesia is rapid, muscle relaxation is complete, it is technically simple, low local 
anaesthetic doses are used, a good quality reliable block is achieved with low failure rates 
of approximately 1.3 %
35 37 59
, length of surgery is mostly ranging between thirty and 
ninety minutes and the patient loads and turnover are extremely high.  
Unfortunately the inability to repeat the block and extended postoperative analgesia is a 
major limiting factor 
35 37 59
. 
2.3  Spinal Anaesthesia 
Spinal anaesthesia is a simple technique that entails injection of small doses of local 
anaesthetic solution into the subarachnoid space 
52 55
.    
 
2.3.1 History of Spinal Anaesthesia 
Spinal anaesthesia was developed over 100 years ago. It has been more than 25 years since 
neuraxial opioids first underwent rigorous clinical study for use in humans. Spinal 
anaesthesia was accidentally discovered by J. Leonard Corning of New York in 1885 
during experiments with anaesthetic drugs in dogs 
53 60 61 
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It was first used in human beings in 1898 by Dr August Bier, who employed an assistant to 
inject cocaine into his own spine. In 1891 Quinke developed the technique of lumbar 
puncture and the importance of small bore fine needles.  
The first described cases of spinal anaesthesia use in the United States were in October 
1899 by Taut and Caglieri and December 1899 by Dr Rudolf Matas where spinal 
anaesthesia was employed for an osteotomy of the tibia and haemorrhoidectomy 
respectively. In 1907 Barker, in England and Chaput in France worked out the principles of 
gravity and the technique of „heavy‟ injection with 5% glucose.  
Spinal analgesia in obstetrics was first used by Kreis, a German, in 1901. It was 
popularized in the United States by Pitkin in 1928. For years after the first applications of 
spinal anaesthesia in obstetrics by Kreis, Doloris and Malartic in 1900s, this method of 
analgesia was condemned due to the high degree of complications, poor results and the 
lack of understanding of the interaction between the physiologic changes associated with 
pregnancy and the changes associated with spinal anaesthesia. It wasn‟t until the 1940‟s 
when Adriani and associates established safe, standardised techniques that this method of 
analgesia became popular in obstetrics 
53 60 61
. Since the 1950‟s it has become a widely 
used method of analgesia and anaesthesia in obstetrics
 62
.  
 
2.3.2   History of drugs used in spinal anaesthesia 
 
Originally drugs used in spinal anaesthesia included cocaine, stovaine, strychnine, 
novocaine and spinocaine. New amino ester local anaesthetics, such as tropocaine, eucaine, 
benzocaine, and tetracaine, were synthesized between 1891 and 1930 
63
.  
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The amino amide local anaesthetics were prepared between 1898 and 1972 and included 
procaine, chloroprocaine, cinchocaine, lidocaine, mepivacaine, prilocaine, bupivacaine, 
etidocaine and articaine
63
. 
All these drugs were less toxic than cocaine but they had differing amounts of central 
nervous system and cardiovascular system toxicity.  
Bupivacaine was synthesized in 1957 and has become the most commonly used local 
anaesthetic agent for spinal anaesthesia in obstetric patients 
63
. Its popularity stems from its 
long duration of action, low cost, reliability, and safety profile.  
 
 
2.3.3  Mechanism of action of a spinal anaesthetic 
The principal site of action for neuraxial blockade is the nerve root. Local anaesthetic is 
injected into the CSF and bathes the nerve root in the subarachnoid space 
 52 53 55
.  
Hogan and Toth have shown that the sizes of the nerve roots of the spinal cord differ 
between individuals and that this difference may explain the inter-patient differences in 
neuraxial block quality when an equivalent technique is used. Although dorsal (sensory) 
roots are larger than anterior (motor) roots, the dorsal roots are often blocked easier. This is 
explained by the organization of the dorsal roots into component bundles, creating a much 
larger surface area on which the local anaesthetics act 
 52 53 55 66
. 
Direct injection of local anaesthetic into CSF for spinal anaesthesia allows a relatively 
small dose and volume of local anaesthetic to achieve dense sensory and motor block. 
Blockade of neural transmission in the posterior nerve fibres interrupts somatic and 
visceral sensations, whereas blockade of anterior nerve root fibres prevents efferent motor 
and autonomic outflow. Neuraxial blocks can provide excellent operating conditions by 
interrupting the transmission of painful stimuli and abolishing skeletal muscle tone below a 
certain dermatomal level
52 53 55
.  
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The factors which determine and affect this level are discussed later in this chapter. 
Sensory block interrupts both somatic and visceral pain stimuli below this level, and motor 
blockade produces skeletal muscle relaxation
53
.    
2.3.4  Local anaesthetic and opiate use in spinal anaesthesia 
There are many choices of drugs available to produce spinal anaesthesia, however local 
anaesthetics are used most frequently
52 53 55
.  
When choosing a drug for subarachnoid injection, the duration of the block and analgesia 
obtained should be taken into account. Commonly used anaesthetic agents include 
procaine, lidocaine, mepivacaine, tetracaine, ropivacaine, levobupivacaine and bupivacaine 
52 53 55
. 
These drugs provide analgesia which may range between 45-400 minutes. Doses of 
Bupivacaine usually range between 1.8 and 2.9ml 0.5% hyperbaric bupivacaine to achieve 
a block below the T4 dermatome 
1-13
. 
The analgesia obtained from spinal anaesthesia has a short duration. This duration may be 
extended by the addition of opioids and other adjuncts. A systematic review of 
intraoperative analgesia identified that approximately 24% of patients that receive only 
hyperbaric bupivacaine experience unacceptable levels of discomfort during spinal 
anaesthesia for caesarean section. Plain bupivacaine may be associated with intraoperative 
nausea during manipulation of the uterus at the time of peritoneal closure. This is effect 
may be decreased by the addition of opioid to the block
52 53
. 
Neuraxial administration of opioids in conjunction with local anaesthetics improves the 
quality of intraoperative analgesia, decreases intraoperative discomfort and prolongs the 
duration of postoperative analgesia 
1-13 58 59 73
.  
22 
 
However, they also produce several side effects, including pruritis, nausea, vomiting and 
respiratory depression in a dose-dependent fashion 
58 59 73
.  
A dose of 0.1-0.2 mg morphine added to intrathecally administered local anaesthetics has 
been demonstrated as the best balance between the improvement of the quality of pain 
control and minimization of side effects 
7
. Morphine, because of its relative hydrophilicity 
in comparison to other opioids, also has an enlarged potential for rostral migration in the 
CSF. This may possibly lead to a late respiratory depression 
7
. Lipophilic opioids, like 
fentanyl and sufentanil, have a faster onset of action and lower risk for delayed respiratory 
depression. Lipophilic opioids are much more frequently used to potentiate nerve block of 
local anaesthetics. Literature indicates that intrathecal fentanyl is used in more than 40% 
obstetric anaesthetics. Doses range between 15 to 25 µg 
1-13
.  Morphine provides good 
quality long postoperative analgesia but little intraoperative effect because of the slow 
onset imposed by its relatively poor lipophilicity 
52 53 55 67
. Studies have shown 
antinociceptive synergism between intrathecal opioids and local anaesthetics 
1-13
.   
Fentanyl prolongs the duration of bupivacaine-induced sensory block by 28% 
1-13
. The 
synergism between opioids and local anaesthetics is due to the effect that they exert their 
antinociceptive effect in the spinal cord by different mechanisms
52 53 67
. The inclusion of 
fentanyl may provide more than an hour of additional analgesia compared with hyperbaric 
bupivacaine alone 
1-13
. It is important to use the smallest effective opioid dose to minimize 
potentially adverse maternal and neonatal risks
67
. Beneficial analgesia has to be balanced 
against known adverse effects, which include respiratory depression, emetogenesis, and 
pruritis
52 53 67
. Intraoperative respiratory depression and increased sedation occur when 
doses of more than 40 µg are used
53 67
.  
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Studies indicate that in order to maximize postoperative analgesia, whilst minimizing 
respiratory depression and pruritis, a dose of approximately 20 µg would be optimal 
1-13 53
.  
Opioids have a dose sparing and synergistic effect with regards to Bupivacaine 
1-13
. The 
lower dose of Bupivacaine needed decreases the risk of side effects and toxicity. The 
mechanisms by which opiates create a block will be discussed later in this chapter. 
Unfortunately pain relief provided by opioids shows inter-individual variability depending 
on factors such as previous exposure, increase in nociception, drug interactions and 
emotional status 
1-13
; all factors that may be present in patients diagnosed with HIV 
infection
68
. 
2.3.5  Mechanism of action of local anaesthetics 
The effect of local anaesthetics on nerve fibres varies according to the size of the nerve 
fibre, whether it is myelinated, and the concentration achieved and the duration of contact. 
Spinal nerve roots contain varying mixtures of nerve fibres. Smaller and myelinated fibres 
are generally more easily blocked than larger and unmyelinated ones. Neurons have 
membrane-bound, voltage-gated sodium and potassium channels that produce membrane 
depolarization following chemical, mechanical and electrical stimulation. Sodium channels 
are membrane-bound proteins that are composed of one large alpha subunit through which 
sodium ions pass and one or two smaller beta subunits. Voltage-gated sodium channels 
exist in three states- resting, activated (open) and inactivated 
52 53 55 67
.  
If the depolarization exceeds a threshold level of about -55mV, voltage-gated sodium 
channels are activated, allowing a sudden influx of sodium ions and generating an action 
potential. Local anaesthetics bind the alpha subunit and block voltage-gated sodium 
channels from inside the cell 
52 53 55 67
.  
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Once the local anaesthetic has blocked the channel, transmission of the impulse is stopped, 
and hence the action of the nerve is blocked, with resultant clinical effect
52 53 55 67
.
 
With 
increasing concentrations of anaesthetic neural impulse conduction slows, the rate of rise 
and magnitude of the action potential decreases, and the threshold for excitation is raised 
progressively until an action potential can no longer be generated and impulse propagation 
ceases
67
. 
 
Local anaesthetics have a much greater affinity for the channel in the activated and 
inactivated state than in the resting state. Local anaesthetics may also block calcium and 
potassium channels and N-methyl-D-aspartate  (NMDA) receptors to varying degrees
67
.  
2.3.6  Mechanism of action of opioid anaesthetics 
Administration of opioids into the subarachnoid space may produce a marked and selective 
inhibition of the small fibres A and C involved in the conduction of pain sensation. 
Fentanyl is a µ- receptor agonist that exerts its action by opening potassium channels and 
reducing calcium influx, resulting in inhibition of transmitter release. It also has a direct 
postsynaptic effect, causing hyperpolarisation and reduction in neuronal activity. 
Intrathecal fentanyl exerts its effect primarily at the level of the spinal cord but systemic 
absorption may cause an effect of peripheral receptors
53 67
. 
Varassi et al. have demonstrated that the subarachnoid administration of 25 µg of fentanyl 
during spinal anaesthesia in a non-premedicated patient did not alter respiratory rate, end-
tidal tension of carbon dioxide, minute ventilation, respiratory drive, respiratory timing or 
the ventilatory response to carbon dioxide 
10
. 
Side effects of high dose intrathecal opiates include postoperative nausea and vomiting 
(PONV), in approximately 30% of cases, and pruritis 
52 53 67
.  
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These side effects are usually easily managed. PONV can be prevented or treated with 
cyclizine , and severe pruritis, is ameliorated with intravenous naloxone titrated to achieve 
an effect without abolishing analgesia
52 53 67
. 
2.3.7  Factors affecting block height  
More than twenty factors may alter spinal block height and therefore time to full regression 
of block and need for additional analgesia
52 53
. The height of spinal block is thought to be 
determined by the cephalad spread of local anaesthetic within the cerebrospinal fluid 
(CSF).  Table 2.1 lists the most important factors associated with block height. Factors 
include patient specific factors, the technique of injection, characteristics of the spinal fluid 
and anaesthetic solution
52 53
. Many of these variables have been shown to be of negligible 
clinical importance. Baricity of the local anaesthetic solution relative to patient position is 
probably the most important. Baricity is defined as the ratio of the density of the local 
anaesthetic solution relative to the density of CSF, which averages 1.0003 g/ml-1. 
Solutions which have the same density as CSF have a baricity of 1.0000g/ml-1 and are 
termed isobaric. Solutions that are denser than CSF are termed hyperbaric, whereas 
solutions that are less dense than CSF are termed hypobaric
53 69 70
.  
Isobaric bupivacaine in saline has a baricity of 0.9983 g/ml-1. Hyperbaric bupivacaine in 
dextrose has a baricity of approximately 1.0227 g/ml-1. Baricity is an important 
determinant in the spread of local anaesthetic because gravity causes hyperbaric solutions 
to flow downward in the CSF to the most dependent regions of the spinal column. 
Hypobaric solutions tend to rise in the CSF leading to a high block height and possible 
significant cardiovascular compromise
58 74 75
.  
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The sitting position has a marked influence on the distribution of hypobaric and hyperbaric 
solutions because this accentuates the effect of gravity. Spinal curvature also affects the 
movement of injected solutions 
58 74 75
.  
Hyperbaric solutions injected at the height of the lumbar lordosis will tend to flow 
cephalad to pool in the thoracic kyphosis thus the clinical observation that hyperbaric 
solutions tend to produce blocks with an average height in the midthoracic region. 
Temperature may alter the baricity and thus alter the block height. Increasing temperature 
may decrease baricity
52 71
. 
 
Several studies have shown that neither the injected volume nor the drug concentration 
affect block height when the dose is kept constant 
53 72 73
. 
The site of injection can have an important effect on block height when isobaric solution 
are administered 
53 74
. Injection in the L3-4 interspace led to a block height of T6, whereas 
injection at the L4-5 interspace reduced the block height to T10 
53 74
.  In contrast, Sundnes 
et al. found no relationship between injection site and block height when hyperbaric 
solutions are used, presumably because of the overwhelming effect of gravity and position 
on distribution of local anaesthesia 
53 73
.
 
In young adults the most important variable governing block height with hyperbaric local 
anaesthetic solutions may be lumbosacral CSF volume
53 75
. 
  
Higuchi and colleagues 
performed a detailed examination of the effect of lumbar CSF volume, CSF density, 
lumbar CSF motion, patient age, weight, height and BMI on spinal block. Multiple linear 
regressions demonstrated that neither patient age nor height correlated with any clinical 
characteristics of spinal block. However CSF volume and weight were correlated with 
peak block height 
53 76-82
.  
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Although these variables were statistically significant, the coefficients of determination 
were small, indicating that these variables account for a relatively small amount of the 
variability in the block height 
53 76-82
.
 
Table 2.1.  Factors that alter spinal anaesthetic block height
52 53
.
 
 
2.3.8  The post-dural puncture headache and backache post spinal anaesthetic   
When properly conducted, spinal anaesthesia can be safely administered 
83
.   
Postdural puncture headaches (PDPH) and backache are common but rarely significant 
complications of spinal anaesthesia in pregnant woman. PDPH has an incidence as high as 
25% in some studies 
84
. 
 
PDPH  is a complication of puncture of the dura mater which 
typically presents hours after puncture and presents with headache and nausea that 
typically worsen when the patients assumes an upright posture 
53
.  
It is thought to result from a loss of cerebrospinal fluid through the meningeal needle hole 
resulting in decreased buoyant support for the brain 
53
.  
Patient 
characteristics 
 
Technique of 
injection 
 
Characteristics of spinal 
fluid 
 
Characteristics of 
anaesthetic solution 
 
 
Volume of 
cerebrospinal fluid 
Site of injection 
 
Volume 
 
Density 
Density of 
cerebrospinal fluid 
Direction of needle Pressure (cough, strain, 
valsalva) 
Amount (mass) 
 
Age Direction of bevel Density 
 
Concentration 
 
Height Rate of injection  Temperature 
 
Weight   Volume 
 
Gender   Vasoconstrictors 
Intra-abdominal 
pressure 
   
Anatomic 
configuration of 
spinal column 
   
Position    
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A decreased hydrostatic pressure in the subarachnoid space then leads to traction on the 
meninges with associated symptoms. The incidence of PDPH is less than 1% with small 
gauge pencil-point spinal needles. The smaller gauge results in less CSF leakage and the 
pencil-point spreads the collagen fibres of the dura rather than cutting them. The headache 
is usually mild and resolves with conservative treatment including bed rest, hydration, 
simple analgesia and caffeine 
52 53 84 85
. 
Backache is a common complaint, but not a true complication, as it occurs with most 
caesarean sections under spinal and general anaesthesia. It is usually mild and self-limited. 
The aetiology of backache is not clear but may be related to position during surgery, length 
of surgery, needle trauma, local anaesthetic irritation and ligamentous strain secondary to 
muscle relaxation 
52 53
.    
Pregnant women are at a higher risk for the development of postdural puncture headache 
52 
53
. The occurrence of postdural puncture headache and backache may alter the 
postoperative analgesic requirements.        
The pain from PDPH or backache may be worse than the pain due to the surgery itself.  
Patients may request analgesia not for the surgical pain but for the back or headache. 
Factors increasing the incidence of postdural puncture headache are listed in Table 2.2 
52 53 
Table 2.2 Factors affecting the incidence of postdural puncture headache
52 53
.
 
 
Age Younger more frequent 
Gender Females  greater than males 
Needle gauge Larger greater than smaller 
Needle bevel Less when needle bevel is placed in the long axis of neuraxis 
Pregnancy Increased when pregnant 
Number of 
Dural punctures 
Increased with multiple punctures 
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2.4  Pain 
The word pain was derived from the Latin word Poena which means “punishment”86.Pain 
is defined by the International Association for the Study of pain as “an unpleasant sensory 
and emotional experience associated with actual or potential tissue damage” 87. The relief 
of pain has been one of the primary reasons for the development of health care.  
In modern anaesthetic practice the prevention of intraoperative pain continues to expand to 
encompass postoperative care and treatment and prevention of acute and chronic pain 
32
. 
Despite many advances in the provision of pain services, acute pain after surgery remains a 
significant cause of morbidity 
30 31 33 88
. Patient satisfaction is one of the most important 
factors in the assessment of surgical outcome 
28
. Patient satisfaction is a multidimensional 
measure with analgesia being one of the most important determining factors 
33
. 
Expectations for an excellent experience are high in healthy obstetric patients 
35
. 
Pain accompanies more than 23 million surgical procedures each year but is managed 
inadequately in more than half of these patients 
33 89
. The provision of adequate 
postoperative analgesia has become one of the most fundamental aspects of anaesthetic 
care. Inadequate postoperative pain control can have a negative impact on both the mother 
and infant 
26 55
. Numerous deleterious effects of post-operative pain in obstetric patients 
have been described 
90
. 
 Pain has been experienced to some degree by everyone, regardless of age, status, or 
economic level. The word can evoke fear. Experience with pain can leave lasting 
emotional and physical impressions. The experience of pain can therefore be altered by 
preoperative expectation of a negative event, such as a prior experience of inadequate 
analgesia 
91 92
. 
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 2.4.1  Definition and classification of pain 
Pain has been introduced as the fifth vital sign by the Joint Commission on Health Care 
Organization (JCAHO) 
93
. Pain is derived from the Latin word Poena which means 
punishment 
86
. Pain is not just a sensory modality but is an experience
86
. The International 
Association for the Study of Pain defines pain as “unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of such 
damage”94. The relief of pain has been one of the primary reasons for development of 
health care. 
Pain is can be classified into acute, chronic, physiological, pathophysiological (nociceptive 
or neuropathic) or by aetiology (e.g. postoperative or cancer pain), or by the affected area. 
Classifications are useful in the selection of treatment modalities and drug therapy
67 95 96. 
Physiological pain describes the situation where a noxious stimulus activates peripheral 
receptors, which transmit the information until it reaches the brain and is recognized as 
harmful stimulus. This entity is often referred to as incisional pain 
52 67 95 97
. Physiological 
pain is expected with any surgery, and the magnitude is in keeping with the degree of 
tissue damage
 52 55 67 95
. 
In pathophysiological pain inflammation or nerve damage gives rise to changes in sensory 
processing at peripheral and central level with a resultant sensitization 
52 53 55
. Stimuli, 
which normally do not produce pain, are perceived as painful (allodynia) and there is an 
exaggerated response to painful stimuli (hyperalgesia) once sensitization occurs 
52 53 55
. 
More than 50% of patients continue to have severe pain after surgery and trauma. Evidence 
shows that inadequate analgesia increases the risk of postoperative complications and may 
lead to persistent (chronic) pain
98
. Surgery and injuries are considered to contribute to at 
least 25% of the burden of chronic pain
99
.  
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2.4.2   Factors influencing the experience of pain 
The response and interpretation of pain can be highly variable among persons as well as in 
the same person at different times
100
.Physiological, psychological, social, emotional, 
educational, ethnic, cultural, cellular, molecular, and genetic factors, may all have an 
impact on the generation and perception of pain
 101-103
. According to published literature, 
females demonstrate a lower pain threshold and lower tolerance of painful stimuli 
104
.  
2.4.3   Acute pain and pain associated with caesarean section   
Acute pain can be defined as pain that is caused by noxious stimulation due to injury, a 
disease process, or the abnormal function of muscle or viscera 
52
. It is usually nociceptive. 
“Nociceptive pain” has been introduced as the term for the usual mode of pain that is 
generated by an injury that activates nociceptors in peripheral tissue
87
.  Nociceptive pain is 
used to detect, localize, and limit tissue damage. Four physiological processes are 
involved, namely transduction, transmission, modulation, and perception. This type of pain 
is usually associated with a neuroendocrine stress that is proportional to intensity 
52
.  
Acute pain includes posttraumatic, postoperative, and obstetric labour pain as well as pain 
associated with acute medical illness 
52
. Excitatory chemical mediators of pain include 
substance P, calcitonin-gene-related peptide, glutamate, aspartate and adenosine 
triphosphate as well as other inflammatory mediators such as those listed  in Table 2.3 
52
.  
Neurotransmitters that inhibit the transmission of pain signals include somatostatin, 
acetylcholine, enkephalins, beta-endorphins, norepinephrine, adenosine, serotonin, gamma-
aminobutyric acid (GABA) and glycine 
52
.   
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Table 2.3.  List of inflammatory mediators 
52
. 
 
Hydrogen ions Histamine Purines Leukotrienes 
Noradrenaline Potassium ions Cytokines Nerve growth factor 
Bradykinin Prostaglandin Serotonin Neuropeptides 
 
        
Typically acute pain is self-limited or resolves with treatment in a few days or weeks 
67 95
. 
Two types of acute pain exist, somatic and visceral 
52
. They are differentiated by origin and 
characteristic features 
 52 67 95
.  
Somatic pain can be further classified as superficial or deep. Superficial somatic pain is 
due to nociceptive input arising from skin, subcutaneous tissue, and mucous membranes. It 
is characteristically well localized and described as a sharp, pricking, throbbing, or burning 
sensation 
52 67 95
.Deep somatic pain arises from muscle, tendons, joints or bones. In contrast 
to superficial somatic pain, it usually has a dull, aching quality and is less well-localised. 
Both the intensity and duration of the stimulus affect the degree of localization 
52
. 
The visceral form of acute pain is due to a disease process or abnormal function of an 
internal organ or its covering (parietal pleura, pericardium, or peritoneum). Four types are 
described, namely true localised visceral pain, localized parietal pain, referred visceral 
pain, and referred parietal pain
95
.  
Pain is conducted along three neuron pathways that transmit noxious stimuli from the 
periphery to the central cortex. Primary afferent neurons are located in the dorsal root 
ganglia, which lie in the vertebral foramina at each spinal cord level 
52 67 95
 .  
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Each neuron has a single axon that bifurcates, sending one end to the peripheral tissues it 
innervates and the other into the dorsal horn of the spinal cord. In the dorsal horn, the 
primary afferent neuron synapses with a second order neuron whose axons cross the 
midline and ascend in the contralateral spinothalamic tract to reach the thalamus 
52 67 95
.   
Second order neurons synapse in thalamic nuclei with third-order neurons, which in turn 
send projections through the internal capsule and corona radiata to the post central gyrus of 
the cerebral cortex 
52
.  
Most nociceptors are free nerve endings that sense heat, mechanical and chemical tissue 
damage. Cutaneous nociceptors are present in both somatic and visceral tissues. Primary 
afferent neurons reach tissues by travelling along spinal somatic, sympathetic, or 
parasympathetic nerves. Somatic nociceptors include those in skin (cutaneous) and deep 
tissues (muscle, tendons, fascia, and bone). Visceral nociceptors include those in internal 
organs 
52
.  
Causes of pain from a caesarean section arise from stimuli arising from the skin, 
subcutaneous tissue, abdominal muscles, visceral and parietal peritoneum, the uterus and 
bladder 
105 106
.  
Surgery produces a biphasic insult on the human body. First of all, there is trauma to 
tissue, which produces noxious stimuli and great nociceptive input.   Secondly, there is 
inflammatory process at the site, which is responsible for noxious input. Both of these 
processes sensitize the pain pathways 
52 67 95
.  
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Inadequate postoperative pain control in obstetric patients is postulated to have a severe 
impact on both the mother and infant. Delayed ambulation, impaired dietary intake, 
inadequate respiration, thromboembolism, ileus, atelectasis, pneumonia, depression and 
abnormal development of the infant due to impaired nursing activities are well postulated 
complications. Poorly controlled postoperative pain is thought to increase the likelihood of 
chronic pain 
16
 
55 96
. 
2.4.4  Chronic pain and other complications of acute pain  
Chronic pain is defined as pain that persists beyond the usual course of an acute disease or 
after a reasonable time for healing to occur 
96 99
. This period can vary from one to six 
months or even longer if the source of pain persists. Chronic pain may be nociceptive, 
neuropathic, or mixed 
99
. Psychological mechanisms or environmental factors frequently 
play a major role in the development of chronic pain 
99 107
. The most common forms of 
chronic pain include those associated with musculoskeletal disorders, chronic visceral 
disorders, lesions of peripheral nerves, nerve roots, or dorsal root ganglia, lesions of the 
central nervous system, and cancer pain 
99 107
.  Chronic post surgical pain is more common 
than realised, especially after certain types of surgery e.g. thoracotomy and mastectomy 
99
.  
 
Predictive factors for developing continuing pain include preoperative pain, repeat surgery, 
prolonged surgery, severe postoperative pain, surgical approaches with a higher risk of 
nerve damage, chemotherapy, radiation therapy, and some psychological and depressive 
symptoms. Chronic pain after caesarean section seems to be a significant problem in at 
least 5.9% of patients 
108
.  
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2.4.5  Managing postoperative pain 
 
Postoperative pain is a major medical and nursing challenge for many hospitals. 
Inadequate postoperative pain management is an international problem and the need to 
improve its management is well documented 
26 29 31 100 111
. This is especially so in the South 
African setting, where high patient to staff ratios as well as poorly developed postoperative 
pain services exist. Fear of uncontrolled post surgical pain is a primary concern in many 
patients about to undergo surgery 
112
. Postoperative pain is a potent trigger of the stress 
response, it activates the central nervous system, and it is thought to be an indirect cause of 
adverse effects on various organ systems 
113
 .  
The quality of pain control that can be achieved is more often a function of the time and 
resources devoted to it, rather than the actual regimens employed 
26 29 31 100 111
. A well-
coordinated multidisciplinary approach will achieve the best results and „acute pain control 
teams‟ are being established in many hospitals with this aim 26 29 31 100 111. The use of an 
acute pain service, including anaesthesiologists together with specially trained nurses and 
physiotherapists, often has a considerable impact on pain management on the surgical 
wards 
26 29 31 100 111
. 
Mandatory training programmes in postoperative pain management for all involved staff, 
including surgeons and ward nurses are advocated. Guidelines and protocols should be 
made easily accessible 
26 29 31 100 111
.Regular staff meetings with representatives from the 
acute pain service team should take place in order to evaluate the effectiveness of the pain 
service as well as to discuss difficulties encountered 
26 29 31 100 111
. Pain management needs 
to become a greater priority. Shared responsibility, regular and accurate pain assessment 
and multimodal treatment need to be instituted to ensure improvement 
26 29 31 100 111
.  
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2.4.6   Measurement of pain 
An important effect of recording of pain assessment scores is that it increases awareness of 
the need for analgesia which may improve quality of pain control 
114-116
. 
Most commonly adopted methods for measuring pain involve rating scales. These include 
the Verbal Descriptor Scale / Verbal Rater Scale (VDS/VRS) developed by Keele in 1948 
(Figure 2.1), the numeric rating scale (NRS) described by Downie et al. in 1978 (Figure 
2.2), and the Visual Analogue Scale (VAS) developed by Clarke and Spear in 1964 (Figure 
2.3) 
94 114 117 118
. 
 
 
Figure 2.1. A depiction of the verbal descriptor scale
110
. 
 
 
Figure 2.2. A depiction of the numeric rating scale
 110
. 
 
 
Figure 2.3 a depiction of the visual analogue faces scale
 110
. 
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Keele devised the VDS based on three to five numerically ranked words such as „none‟, 
„slight‟, „mild‟, „moderate‟, and „severe‟, for assessing responses to analgesia over a 24-
hour period 
114
.  
Twenty years later, in 1968, Melzack and Casey introduced the Present Pain Intensity 
(PPI) scale and the McGill Pain Questionnaire (MPQ); this was a five-point scale with an 
intensity range from „no pain‟ through to „excruciating pain‟ 114. 
Unfortunately, there exists the potential for ambiguity in some of the words used. „Mild‟ to 
one person may mean „slight‟ pain to another. Severity of pain can also be confused with 
its frequency. For example, pain may be severe but not experienced very often. Someone 
may therefore describe this pain as mild 
94 114 116 117 119
. 
Downie et al. described the NRS as either a horizontal or vertical line with „0‟ indicating 
no pain, located at the bottom or one extremity and „10‟, indicating severe pain, at the top 
or the other. The main advantages of the NRS are its simplicity of administration, scoring, 
and use, and the fact that it does not involve a need for knowledge of the English language 
114
.  
There is no potential for ambiguity of words, as numbers are used. Its main disadvantage is 
its unreliability for elderly or very young patients, who may not be able to differentiate 
between the numbers 
113
. Although the NRS does have more categories than the VDS, they 
are both composed of discrete categories, of which the respondent must choose only one 
114
. 
In adults, postoperative pain is most frequently measured using a linear visual analogue 
scale (VAS) 
115
.  
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The VAS is a sensitive, simple, efficient, minimally intrusive, reproducible method that 
correlates well with other reliable methods 
114 119 120
. The VAS was first developed over 70 
years ago by Maxwell and is possibly the most widely used assessment tool in the 
measurement of pain 
92 114
. The scale consists of a line, usually 10cm (100mm) in length. 
The VAS line indicates extremes of the sensation being measured. The left side represents 
„no pain‟ and the right side represents „unbearable pain‟. The patient is asked to mark a 
point on the line that indicates their current degree of sensation. Intensity of sensation is 
scored by measuring the millimetres from the left-hand end of the scale to the mark made 
by the patient, thereby obtaining a number between 0 and 100 (or 0 and 10) that represents 
the severity of pain 
92 114 115 119 120
. 
Some authors have claimed that the VAS is confusing. However, it has been reported that 
only 7% of patients could not use it after a single explanation 
114
. The VAS may be 
difficult to use in the postoperative period because of the effects of the anaesthetic, 
sedation, nausea or blurred vision. Patients with motor problems might experience 
difficulty in completing the scale
 92 114 115 119 120
. However, this limitation was remedied by 
Choiniere and Amsel, in 1996, who developed a visual analogue thermometer (VAT) 
114
.  
The later is very similar to the VAS and consists of a plasticized card with a red band 
which can be moved from left (no pain) to right (unbearable pain)
 114
.  
The reliability of VAS is well documented in the literature. Many authors have feared that 
the sedative effects of spinal anaesthesia, especially when opioid anaesthetics have been 
included, may alter the patient‟s response to the VAS. The VAS has, however, been shown 
to be sensitive tool despite the sedative and stimulant effects of drugs 
92  115 119 120 121
.  
The “faces” pain scale is another scale described. It is more useful in patients with whom 
communication may be difficult or when language barriers exist 
117 122
.  
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The patient is asked to point to various facial expressions ranging from a smiling face (no 
pain) to an extremely unhappy one that expresses the worst possible pain 
117 122
. 
 2.5 HIV/AIDS  
In 2007, there were 33 million people who were living globally with HIV and 2.7 million 
were newly infected 
125
. South African has one of the highest prevalence rates of HIV 
infection in the world 
130
. There are an estimated 5.5 million people infected with HIV in 
South Africa, many of whom are unaware of their status 
130
. The majority of HIV 
infections occur in individuals of reproductive age, and more than half of these are women 
131
. More than 90% of the children infected with HIV globally were as a result of vertical 
mother-to-child transmission 
39 40 129 133
. South African surveys place antenatal prevalence 
in the range of 15%–40.7%, with a national average of 29.1% 134.  
 
2.5.1  Antiretroviral therapy 
 
Antiretroviral therapy has been described as the greatest advancement in the treatment of 
HIV infection. The course of HIV disease has been drastically altered by the development 
of highly active anti-retroviral therapy (HAART).  HAART has led to  HIV/AIDS 
becoming more of a chronic disease state rather than a progressive terminal illness
 137
.  
 
Drugs for treatment of HIV infection are classified into several classes according to the 
mechanisms of inhibition of viral replication. The four classes most commonly used are  
reverse transcriptase enzyme inhibitors, protease enzyme inhibitors, integrase inhibitors 
and entry inhibitors 
95 125 137
. 
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Drug interactions commonly occur due to the polypharmacy that exists in the treatment of 
HIV-positive patients. Drug interactions include effects on the efficacy, toxicity, 
absorption, distribution, metabolism and elimination of drugs. HAART may also cause 
renal and hepatic dysfunction 
125 137
. 
  
Altered pharmacokinetics is a more complicated interaction, and is mostly mediated 
through inhibition or induction of hepatic liver enzyme, particularly CYP450 (CYP) 3A4 
enzyme.  Protease inhibitors (PIs) (e.g. Saquinavir, Ritonavir, Indinavir, and Lopinavir) 
and NRTI‟s (e.g. Zidovudine, Lamivudine, and Tenofovir) are the most implicated in drug 
interactions. It is postulated that these drugs may reduces fentanyl clearance and therefore 
prolong its clinical effects as well as side-effects 
125 137
. Drug interactions, and altered 
pharmacodynamics and pharmacokinetics may alter the duration of analgesia obtained 
from spinal anaesthesia. 
   
 2.5.2  HIV/AIDS and the nervous system 
 
The central and peripheral nervous systems are frequently affected by HIV/AIDS 
140
.  
The presence of neurological manifestations, such as overt dementia, may impair the 
ability of the patient to provide preoperative consent and may increase brain sensitivity to 
sedative or psychoactive drugs (opioids, benzodiazepines, and neuroleptics).  
Opportunistic infections may be associated with increased intracranial pressure. Increased 
intracranial pressure and central nervous system infections (meningitis, encephalopathy, or 
myelopathy) are contraindications to neuraxial anaesthesia. 30% of adults and 50% of 
children suffering from AIDS will develop neurological disorders 
141 142
.  
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Neurologic involvement may be due to the virus itself such as direct infection, 
inflammation, demyelination or degenerative process 
141 142
.  
 
The diagnostic approach to patients with HIV infection and neuropathy, myopathy or other 
neurological deficit consists of taking a comprehensive neurological history and physical 
examination.  
 
Opportunistic infections and neoplasms of the nervous system, secondary to immune 
deficiency, also occur. Every structure within the nervous system may be affected, 
including the meninges, brain, spinal cord, peripheral nerve and muscle 
142 144
.  
 
In the early stage of infection, headaches, photophobia, meningoencephalitis, depression, 
irritability, Guillain-Barre-like syndromes, or cranial and peripheral neuropathies can be 
observed. The latent phase of the disease is associated with demyelinating neuropathy and 
vertebral fluid pathology 
140 142 143
.              
 
The late period of HIV infection is associated with meningitis, focal or diffuse 
encephalopathy, myelopathy, myopathy, and peripheral neuropathy 
140 142 143
.  
HIV-associated neurocognitive impairment (HNCI) is a spectrum of disorders with the 
most severe impairment considered as AIDS dementia complex or HIV encephalopathy. 
Autonomic neuropathy has also been described in HIV-infected individuals. New onset of 
seizures can also occur and can progress to status epilepticus 
140 142 143
.   
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A thorough evaluation of the nervous system should be conducted before performing 
neuraxial blockade. Patients with AIDS may be more sensitive to opioids and 
benzodiazepines as a result of the neurological involvement 
140 142 143
.  
  
HIV infection, intracranial masses, or opportunistic infections may cause cerebral oedema, 
cerebral haemodynamic disturbances, and increased intracranial pressure. Peripheral 
neuropathy is the most frequent neurological complication in HIV patients. It affects 
approximately 35% of patients with AIDS and manifests clinically as polyneuropathy and 
myopathy 
144 145 147
.  
 
Regional anaesthesia has been shown to be associated with reduced morbidity and 
mortality in a wide range of patients, including HIV positive parturients having caesarean 
section under spinal anaesthesia 
51
. Regional anaesthesia has the advantage of not 
interfering with the immune system or with antiretroviral drugs. Relative contraindications 
to regional anaesthesia in these patients include sepsis and bleeding tendencies. The 
presence of neuropathy may reduce the appeal of regional anaesthesia but there is no data 
to contradict its use 
51
. Articles concerning the effect of spinal anaesthesia in 45 HIV 
treated patients under caesarean section showed no perioperative complications or changes 
in immune function or viral load 
51 145
.  
HIV infection causes autonomic neuropathy which may accentuate haemodynamic 
instability caused by spinal anaesthesia. This may be a concern in patients with advanced 
HIV infection 
95
.   
Involvement of neurological system may alter the duration of analgesia obtained from 
spinal anaesthesia. 
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2.5.3   HIV/AIDS and pain 
Visceral, somatic and  neuropathic pain are common and debilitating symptoms of HIV 
disease and are present in approximately 30-62% of HIV patients 
18-20
.  
Pain in HIV can be classified into pain due to the disease itself, as a side-effect of 
treatment or, unrelated to the disease or its treatment 
19
.  People with HIV disease often 
have pain arising from various stimuli occurring concurrently and the pain has profound 
affect on their quality of life 
18 20 34
. Depression, which is frequently present in HIV- 
positive individuals, is associated with increased postoperative pain 
18
.  
Pain experienced by HIV- positive patients includes chest pain, oral cavity pain, headache, 
peripheral neuropathic pain, abdominal pain, anorectal pain, and musculoskeletal pain 
18 20
. 
Pain is associated with significant psychological and functional impairment. Individuals 
with pain have significantly more depressive symptoms, psychological distress, and feel 
more hopeless than those without pain 
18
. Prolonged insult to the body produces changes in 
the nervous system which alter the normal physiological response to a noxious stimulus 
146
. 
Peripheral neuropathy is one of the most frequent neurological complications of HIV 
147
. 
Distal symmetrical polyneuropathy (where the most common pathology is distal 
axonopathy) is the most common form of peripheral neuropathy in patients with AIDS 
147
.   
Several mechanisms have been proposed, including direct infection by HIV, and cytokine 
or inflammatory-mediated neurotoxic effects. Forms of neuropathy other than distal 
polyneuropathy are mononeuropathy multiplex, inflammatory demyelinating 
polyneuropathy, progressive polyradiculopathy, autonomic neuropathy and 
monoradiculopathy 
147
. 
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In chapter 2 we have reviewed the current literature and discussed topics pertinent to this 
research project. This has included discussions pertaining to caesarean sections, spinal 
anaesthesia, HIV/AIDS and pain mechanisms and measurement. 
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CHAPTER 3 – METHODOLOGY 
 This chapter will provide an in-depth description of the methodology used for the study. 
3.1   Study design 
This study was a prospective, randomised, double-blinded, quantitative, observational 
study. 
Prospective: The patients were followed forward in time until the required data was 
collected. 
Randomised:  individuals at the beginning of the study were randomly allocated to one of 
two drug treatment groups according to the order in which they were 
entered on a computer generated list.  
Double-blinded:  The researcher, as well as the anaesthetist administering the spinal 
anaesthetic, were unaware of the patients‟ HIV status or the drug 
treatment that the patient was given. 
Quantitative: The study determined the relationship between one independent variable 
and another dependent variable.     
Observational: The data was collected without any intention of intervening in any aspect of 
the management of the participants. 
This study design was chosen because a double-blinded randomised data collection has 
been recognised to be a robust method, providing a reliable means with which to conduct 
scientific research.  
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The study design chosen would provide an appropriate means to determine the duration of 
analgesia obtained from spinal anaesthesia, utilising different drug treatments in caesarean 
section patients at CHBH, and would enable a comparison of durations of analgesia 
achieved in HIV- positive and HIV- negative individuals. 
3.2   Study Site 
The study was conducted in the obstetric theatre and post-caesarean section ward in the 
maternity wing of CHBH, in Soweto, Johannesburg. CHBH is a 2800-bed tertiary public 
hospital, which services a population in the low-income bracket. There are about 1800-
2000 deliveries and approximately 550-650 caesarean sections performed monthly at 
CHBH
15
. Even though CHBH is a tertiary referral hospital, not all women delivering at 
CHBH require tertiary-level care. 
3.3  Study population 
The study population consisted of women aged between 18 and 45 years, presenting for 
elective caesarean section, who use government-provided health services at CHBH.  
Elective caesarean sections at CHBH are usually performed for patients, who have been 
identified at the antenatal clinic, where either the mother or foetus is at high risk of 
complications related to vaginal delivery, or augmentation of labour. This includes patients 
who have undergone previous caesarean sections where trial of labour is not possible, twin 
pregnancies, abnormal foetal lies, foetal abnormalities and obstructed birth passages e.g. 
severe vaginal papilloma virus infections. HIV infection is currently not an indication for 
elective caesarean section. 
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3.4  Study period 
The data collection was done over a period of 6 months from June to December 2008, with 
the majority of data collected in November 2008.  
3.5  Ethical considerations 
The study was approved by the regional Ethics Committee – the Committee for Research 
on Human Subjects (Medical) of the University of the Witwatersrand (Appendix A). 
The study was approved by the Post-Graduate Committee of the University of the 
Witwatersrand, Faculty of Health Sciences (Appendix B). 
Permission to complete this research project, collect data from patients‟ files and to 
interview patients was granted by the Clinical Director of CHBH (Appendix C). 
The study was conducted in accordance with the principles outlined in the Declaration of 
Helsinki 
25
. 
3.6  Definitions 
The following definitions were used in this study:    
Elective caesarean section: A caesarean section that is performed on a pregnant woman on 
the basis of an obstetrical/medical indication or the request of the patient. The elective 
caesarean section is usually a “planned caesarean section” and usually performed prior to 
labour 
132
.
 
HIV- positive patient: A patient that has tested positive for HIV using a rapid HIV test and 
confirmed using an HIV ELISA test. 
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Time to analgesic requirement: time (measured in minutes) from administration of spinal 
anaesthetic until request of subsequent analgesia, to relieve surgically associated pain, 
postoperatively. 
Ethnicity was defined as an affiliation resulting from racial or cultural ties. Patients were 
presented with four options (Zulu, Sotho, Xhosa or Other) and asked to choose the most 
applicable option available.
 
3.7  Sample population and sampling method 
In consultation with a statistician, it was decided that a minimum of 56 HIV-positive and 
56 HIV-negative patients would be required to determine if a statistically significant 
difference in duration of analgesia existed between the HIV-positive and negative 
individuals. The sample size was calculated assuming a true difference of 20 minutes 
existed between these patients, with a standard deviation of 35 and a power of 85%, with 
the significance level set at p <0.05. 30 patients in each of the four would be required to 
achieve a power of 100% with standard deviation of 35 and alpha value of 0.05 when 
analysed by an ANOVA 1- way test (assuming a normal distribution). Patient study groups 
are demonstrated below in Figure 3.1. and consisted of HIV-positive bupivacaine (HPB), 
HIV-positive bupivacaine and fentanyl (HPBF), HIV-negative bupivacaine (HNB) and 
HIV-negative bupivacaine and fentanyl (HNBF) 
49 
 
  
Figure 3.1 Diagram illustrating study groups.  
Consecutive convenience sampling was used. The hospital runs two obstetric theatres for 
elective and emergency caesarean sections.  
A daily list of all elective caesarean section that were scheduled for surgery was compiled. 
These patients were approached in the antenatal admissions ward for inclusion in the study. 
The selection process stopped once 120 patients with 30 patients in each study groups had 
been recruited. 
             
3.8  Inclusion criteria 
ASA I and II elective patients who had been identified as needing elective caesarean 
sections under spinal anaesthesia for delivery were approached for inclusion in the study. 
3.9  Exclusion criteria 
The following patients were excluded from the study: 
 
Elective C/S pts
(120) 
HIV positive pts
(Study group)
(60)
Spinal anaesthetic with 
bupivacaine
(30)
Spinal anaesthetic with 
bupivacaine and fentanyl
(30)
HIV negative pts
(control group)
(60)
Spinal anaesthetic with 
bupivacaine
(30)
Spinal anaesthetic with 
bupivacaine and fentanyl
(30)
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3.9.1 Patients who were deemed to need emergency surgery. 
3.9.2 Patients who did not obtain an adequate anaesthetic block for surgery. Patients 
who required additional analgesia or sedation intra-operatively. 
3.9.3 Patients younger than 18 years or otherwise unable to give informed consent 
3.9.4 Patients with contraindications pertaining to spinal anaesthesia. 
3.9.5 Patients whose HIV status was not available from their records or who had not 
been tested for HIV during their pregnancy. 
3.9.6 ASA III and IV patients. (According to the American Society of Anaesthetists 
classification ASA III and IV patients are patients with a systemic disease that 
results in moderate to severe functional impairment or a disease which is an 
immediate threat to the patient‟s life) 52 55. 
 
3.10  Data collection 
Patients were invited to participate in the study. Patients received a printed document 
(Appendix D) explaining the reason for the study, exactly what their involvement in the 
study would be, their right to refuse to participate without repercussions to their care, and 
their right to withdraw from the study at any time. A 24-hour contact number was supplied 
should they have required further information. The printed information was provided in 
English.  
The researcher and a translator (anaesthetic nursing assistant) provided verbal information 
in a language that the patient could understand if they could not understand English, or 
were not able to read the document. Patients were requested to sign a consent document 
(Appendix E).  
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Data was then collected from the patients‟ antenatal and hospital records and entered onto 
the data sheet (Appendix D). HIV status, CD4 count and whether the patient was receiving 
antiretroviral therapy was recorded separately by a research assistant or anaesthetic intern. 
If no assistant was available this information was collected after completion of the study. 
Patients‟ names and hospital numbers were kept separate to the data collection sheets, and 
were encoded by a numerical code system. The code was only known to the investigator. 
All information that would link patient identity to the trial results remained separate and 
confidential. A list of syringe codes, and patients details were kept locked away for the 
duration of the study, and remain available only to the researcher.  
Patients were allowed to withdraw their participation at any time, and at no time was a 
patient coerced into participation. 
3.10.1  Patient Information: 
Data capture was managed by entering values onto a separate page for each patient, as well 
as onto a spreadsheet. The details of the collected data are as follows: 
3.10.1.1 Height 
The patients‟ heights were measured by the researcher using a measuring tape. 
Patients were asked to stand against a wall with their feet together and measurements 
were then taken. The patients heights were measured in centimetres and the patients 
were grouped into three categories: 
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i.  140-150 cm  
ii. 151-160 cm  
iii.  more than or equal to 161 cm 
These categories were chosen as most average female patient‟s heights at CHBH 
range between and 140-170 cm. The 10 cm groupings were chosen to simplify the 
height comparisons. 
3.10.1.2 Weight 
The patients‟ weights were measured in kilograms. Weights were taken from the 
antenatal green card from the most recent antenatal visit.  
If no weight was available, or if weights available were taken more than two weeks 
prior to surgery, patients were weighed by the researcher using a calibrated ward 
scale. 
 
3.10.1.3 Age 
 
The age of the patient was recorded in years. 
 
3.10.1.4 Ethnicity 
Ethnicity was defined as an affiliation resulting from racial or cultural ties. The 
patients‟ ethnicities were recorded as one of the four following categories: 
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3.10.1.4.1   Zulu 
3.10.1.4.2   Sotho 
3.10.1.4.3   Xhosa 
3.10.1.4.4   Other          
Patients were presented with the above four options and asked to choose the most 
applicable option available. These categories were chosen because they represented 
the most common ethnic groups of patients attending CHBH as reported during the 
patient interviews. 
3.10.1.5 Education 
The patients‟ levels of education were ascertained. These groups were chosen to   
reflect the educational system as it exists in South Africa. The patients were grouped 
as: 
3.10.1.5.1 Primary  (patients completed primary school but not matriculated) 
3.10.1.5.2  Secondary (patients who had matriculated) 
3.10.1.5.3 Tertiary (patients who had completed a post- matriculation course,    
diploma or degree) 
 
3.10.1.6 HIV status (positive or negative as confirmed by an ELISA test result) 
 
3.10.1.7 CD 4 count 
The CD 4 count result was recorded as the most recently available result in the 
patients‟ records. Patients were grouped as those having CD 4 counts of: 
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3.10.1.7.1   More than and equal to 250 cells/µl 
3.10.1.7.2   Less than 250 cells/µl 
3.10.1.7.3   None available 
Although AIDS is defined as CD 4 count less than 200, these groups were chosen 
because of the South African HAART initiation guidelines, which start HAART in 
patients with CD 4 counts of 250 or less 
150
. 
 
3.10.1.8 Whether the patient was taking antiretroviral therapy (yes or no) 
Patients were considered to be taking antiretroviral therapy if they were taking 
HAART therapy or taking antiretroviral therapy to prevent mother- to- child 
transmission (PMTCT) but did not include those who had obtained only a single dose 
of nevirapine preoperatively. 
3.10.2   Procedure in the operating theatre 
When the patient presented to theatre for surgery intrathecal drugs were be administered in    
a double-blinded fashion utilising pre-mixed coded syringes and a standardised spinal 
technique was utilised. Spinal anaesthetics were administered by, or were overseen by the 
researcher. The content of the syringes was drawn up according to a computer-generated 
random sequence list. The researcher had no knowledge of the content of the syringe. A 
separate log book was kept containing information regarding the patient‟s HIV status, CD 
4 count, ARVs and syringe contents.   
The spinal anaesthetic was performed with the patient in a seated position at the level of 
the L4/L5 interspace.  
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An aseptic technique was utilised. 2ml of 2% lignocaine was infiltrated subcutaneously. A 
25-gauge pencil point needle was employed. CSF was freely aspirated and the contents of 
the syringe injected. 
 
Two spinal anaesthetic options available were: 
 Option 1: 
2ml 0,5% heavy bupivacaine and 0,4ml saline 
Option 2: 
2ml 0,5% heavy bupivacaine and 0,4 ml fentanyl (20ug) 
The starting time of the anaesthetic was measured from the time of injection of the syringe 
contents. Time of administration of anaesthetic was noted on the patient data collection 
sheet and patients were monitored, using the visual analogue, at 30-minute intervals from 
the time of administration of the spinal anaesthetic.  
A visual analogue and faces scale, as shown in Figure 3.2, was administered by the 
researcher to determine post-operative pain scores. 
Patients were monitored postoperatively in both the recovery room and post-surgical care 
ward. Analgesia was given to all patients who requested analgesia.  
Postoperative analgesia was prescribed according to the specific ward protocol and 
generally consisted of Omnopon® 20mg intramuscularly and paracetamol 1g orally.  
When analgesia was requested by the patients, ward nursing staff were informed by the 
researcher, who requested that analgesia be given according to ward protocol. 
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  0   1    2   3   4   5   6   7   8   9  10 
no pain                                        moderate pain                                            worst              
                                                                                                                   Possible pain 
 
Figure 3.2. Example of the visual analogue scale utilised 
22-28
.
 
 
3.11  Data analysis 
The data collected was entered on to a Microsoft Excel ® spreadsheet and submitted for 
statistical interpretation using the Statistica ® version 8.0 computer programme. The 
Shapiro Wilk test was used to test for normality of distribution of the data. The data was 
found to follow a non-normal distribution. We had planned beforehand to analyse the data 
using student t-test and ANOVA test (assuming a normal distribution), but because the 
data followed a non-normal distribution we chose to analyse data utilising the Mann 
Whitney U and/or Kruskal Wallis test, depending on the number of variables to be 
compared. Median, minimum, and maximum values, standard deviation and 95 % 
confidence intervals were determined for the study variables.  
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CHAPTER 4 – RESULTS 
In chapter four the results of the study will be discussed. 
The data collected was entered on to a Microsoft Excel ® spreadsheet and submitted for 
statistical interpretation using the Statistica ® version 8.0 computer programme. Median, 
minimum, maximum values, standard deviation and 95% confidence intervals were 
determined for the various study variables. The data followed a non-normal distribution as 
assessed by Shapiro-Wilk test and therefore, the data was analysed using either the Mann-
Whitney U-test or Kruskal Wallis test depending on the number of variables compared. 
4.1  Sample, patient refusal and exclusion 
A total of 134 patients were approached for possible inclusion in the study. Two patients 
did not give consent because of concerns with confidentiality and fears of victimisation. 
Eight patients were excluded from participating in the study due to unknown HIV status, 
inadequate sensory level blockade, conversion to general anaesthesia, or the need for 
additional intraoperative analgesia or sedation.  
The study consisted of a total of 124 patients. Patients were grouped into 1 of 4 groups. 
The groups were as follows: 
 Group 1:  HIV-positive bupivacaine (HPB) [30 patients] 
 Group 2:  HIV-positive bupivacaine and fentanyl (HPBF) [30 patients] 
 Group 3:  HIV-negative bupivacaine (HNB) [30 patients] 
 Group 4:  HIV-negative bupivacaine and fentanyl (HNBF) [34 patients] 
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4.2   Results related to the primary objective 
4.2.1   HIV infection and the duration of analgesia 
The median duration of analgesia for all HIV- positive patients (HPB + HPBF) was 135 
minutes. The median duration of analgesia for all HIV- negative patients (HNB +HNBF) 
was 138 minutes. These results when analysed utilising a Mann-Whitney U test show no 
significant difference (p-value 0.75).  Median, minimum (Min), and maximum (Max) 
values as well as standard deviation (SD) and 95% confidence intervals (95% CI) for this 
data are represented in Table 4.1 and Figure 4.1.  
4.2.2   Contents of syringe and duration of analgesia 
The duration of analgesia was significantly longer when fentanyl was added to the 
bupivacaine, (p-value 0.00) however; there were no statistical differences in the duration of 
analgesia when considering HIV status. (p-value 0.75) 
The median duration of analgesia for all patients who received bupivacaine (HNB + HPB) 
was 120 minutes. The median duration of analgesia for all patients who received 
bupivacaine and fentanyl (HNBF + HPBF) was 155 minutes.  
Median, minimum (Min), and maximum (Max) values as well as standard deviation (SD) 
and 95% confidence intervals (95% CI) for this data are represented in Table 4.2 and 
Figure 4.2.  
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4.3  Results relating to the secondary objectives 
Median, minimum (Min), and maximum (Max) values as well as standard deviation (SD) 
and 95% confidence intervals (95% CI) and p-values for all secondary objectives are 
represented in Table 4.3  
It was found that CD 4 count (p-value 0.61), Antiretroviral therapy (p-value 0.29), Height 
(p-value 0.20), Ethnicity (p-value 0.30) and Education (p-value 0.44) have no significant 
effect on duration of analgesia.  
Table 4.1 Results pertaining to HIV status 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Key guide used to describe the box-plot graphs depicted in this chapter. 
 
 
 
Variable Median (min) Min(min) Max (min) SD 
95% 
CI 
HIV-positive 135 55 255 41 
                                            
35-50 
HIV-
negative 138 65 280 43 
                                  
37-52 
 : Median 
I  : Min-Max 
 : 25th-75th percentile 
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Figure 4.2.  Boxplot graph depicting the duration of analgesia in HIV- positive and 
negative patients 
 
 
Table 4.2. The duration of analgesia in patients who received bupivacaine and 
fentanyl   comparing HIV status 
 
Variable Median (min) Min (min) Max (min) SD 95% CI 
HPB 118 55 200 26 21-35 
HPBF 160 80 255 37 29-49 
HNB 120 65 140 20 16-27 
HNBF 155 105 280 43 35-56 
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Figure 4.3.  Boxplot graph depicting the duration of analgesia in HIV- positive and 
negative patients according to syringe content 
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Table 4.3 Table representing the result for secondary objectives studied 
 
Variable Subgroup Median (min) Min (min) Max (min) SD 
95% 
CI 
CD 4 count >250  145  75  255  45 36-60  
  <250  130  55  220  39 30-57  
ARV yes  145  55  255  45 36-61  
  no  120  80  225  38 31-51  
Height 140-150  210  150  255  50 28-185 
  151-160  140  65  235  40 34-48 
  >160  130  55  280 41  34-52 
Education Primary  130  65  280  44 37-53 
  Secondary  140  55  260  42 35-53 
  Tertiary  138  90  235  39 28-62 
Ethnicity Zulu  130  75  280  45 38-58 
  Xhosa  125  80  230  37 27-57 
  Sotho  150  55  260  48 38-65 
  Other  140  65  235  34 27-44 
 
 
4.4   Summary of results 
In this chapter the results of the study were discussed. The primary objective (HIV status) 
had no significant effect on duration of analgesia. The addition of fentanyl to the 
intrathecal injection did cause significant prolongation of the duration of analgesia. The 
secondary objectives (CD4 count, antiretroviral therapy, height, and ethnicity) had no 
significant effect on the duration of analgesia obtained from intrathecal injection.  
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CHAPTER 5 – DISCUSSION 
Chapter five will include a discussion of the study in terms of potential limitations of the 
study, implications for clinical practice and further research. Chapter five will also include 
an interpretation of the results of the study, and a discussion of the issues raised by the 
results. In the previous chapter the results of the study were discussed. The null hypothesis 
was accepted as HIV status was found to have no significant effect on duration of 
analgesia. The addition of fentanyl to the intrathecal injection did cause significant 
prolongation of the duration of analgesia. The secondary objectives (CD4 count, 
antiretroviral therapy, height, and ethnicity) had no significant effect on the duration of 
analgesia obtained from intrathecal injection 
5.1     Discussion of results pertaining to the primary outcome 
Current literature states that the addition of fentanyl prolongs the duration of analgesia 
obtained from intrathecal injection. In the literature the duration of analgesia, obtained 
from intrathecal injection, is estimated to be 90 to 190  minutes for intrathecal bupivacaine 
alone and up to 184 (+/- 20) minutes for intrathecal fentanyl and bupivacaine 
1-13
.  
The data collected from this study reflected what has already been described in the 
literature. 
The data collected did not follow a normal distribution curve. This may have been due to 
an inadequate sample size. The non-normal distribution seen may also be a reflection of 
the many factors that impact upon interpretation of pain and individual need for analgesia. 
These factors could not be controlled for.  
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The results of the study showed that HIV infection did not cause a significant alteration in 
duration of analgesia, which may be due to an incorrect sample size, or because of 
incorrect patient selection. The study was designed to determine whether HIV infection 
altered the duration of analgesia obtained from spinal anaesthesia, assuming a 20 minute 
true difference existed between HIV-positive and HIV-negative patients.. It was thought 
that these patients were likely to have neuropathies, pain syndromes or alterations in drug 
metabolism due to drug interactions.
  
It is possible that a study focussing on patients with 
known premorbid neurological pathology would have yielded different results. For the 
purposes of this study, the group of HIV-positive patients were heterogeneous. 
Investigation into different subgroups within the HIV-positive groups may yield more 
information in the future. 
5.2     Discussion of results pertaining to the secondary outcomes 
The sample size was calculated to determine statistical significance with only the primary 
objective in mind. We did not take secondary objectives into account and therefore the 
study is not powered to be able to make any definitive statements regarding the secondary 
objectives and their effect on the duration of analgesia. 
5.2.1   Antiretroviral therapy 
The study was not designed sufficiently so that syringe contents would be randomised in 
patients on HAART .Two-thirds of patients taking antiretrovirals received bupivacaine and 
fentanyl and thus results could be confounded by the addition of fentanyl.  
Patients categorised as receiving anti-retroviral drugs included those receiving HAART 
therapy as well as those that had received antiretroviral therapy as part of therapy to 
prevention-of-mother-to-child-transmission (PMTCT).  
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This was an error and in the future studies it would be necessary to separate out the 
PMTCT group from the long-term HAART patients. The study should have specified 
which drug regimens patients were on and which specific agents they were receiving as it 
is predominantly the protease inhibitors and NRTI‟s that interfere with the clearance of 
fentanyl and the NNRTI‟s that have been implicated in the development of neuropathies 55. 
Further study is needed in order to determine the effect of HAART therapy on the duration 
of analgesia. 
5.2.2   CD4 count 
Majority of patients who had CD4 counts less than 250 were taking antiretroviral therapy.  
It is difficult to discern if the trend observed was due to low CD 4 counts or due to 
confounders such as HAART, drug interaction, presence of opportunistic infections or 
accelerated metabolism of bupivacaine and fentanyl. Further study is needed to define 
whether or not AIDS and/or HAART shorten the duration of analgesia obtained from 
intrathecal injection. 
The study was not originally designed to specifically test the effect of CD 4 count on the 
duration of analgesia. Forty six percent of patients in the study, who tested positive, did not 
have CD 4 counts available. This led to difficulties in assessing the effect of low CD4 
counts on duration of analgesia. Although not related to the study, this indicates failure, 
and a missed opportunity, to follow up and refer positive HIV patients at antenatal clinics 
to specialised HIV clinic.  
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It would have been interesting to have collected data pertaining to  whether these patients 
who tested positive were attending peripheral antenatal clinics or were patients attending 
the CHBH antenatal clinic; and also when these patients presented for the first time to 
antenatal clinic and whether or not they presented late and if that was the reason for the 
missed opportunity.  
A large number of patients in the CD 4 group greater than 250 cells/µl received fentanyl 
and thus the longer durations of analgesia may be a reflection of the effect of fentanyl in 
prolonging the duration of analgesia rather than the effect of the CD4 count.  
5.2.3     Height  
Current literature states that height affects the level of spinal anaesthesia achieved. It is 
surmised that shorter people who received the same volume as taller patients would obtain 
higher levels. With a higher level one would expect a longer duration of analgesia due to 
time taken for block regression. All of the patients in this study were assessed to have a 
sensory block height of T4-T6.             
The results obtained from our study are interesting in that there is no statistically 
significant difference between our three height groups even though the data would at first 
glance appear to be different.  
This may be due to an inadequate sample size but may be also be due to incorrect 
categorisation of heights or the results may have been confounded by an unequal number 
of patients who received fentanyl in the three groups. There may also be a number of other 
confounding variables which we are not aware of and have not taken into account. Further 
study is necessary to determine if height has a statistically significant effect on the duration 
of analgesia.  
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5.2.4    Ethnicity and education  
This study was not adequately powered to determine whether ethnicity and education do in 
fact have no significant effect on the duration of analgesia achieved with spinal 
anaesthesia. The results reflect that perhaps the role of culture in the assessment of pain is 
not as significant as it is thought to be but further study with a larger sample size is needed 
to definitively prove or disprove this.  
It is possible that the different South African ethnic groups may have similar influences on 
their experience of pain, being that they are from similar geographical areas, and that it 
may be interesting to repeat the study looking at more culturally diverse groups. 
5.3.     Potential limitations of the study  
5.3.1.   Study period         
Data was collected by convenience sampling. Practically the majority of data was collected 
consecutively throughout November, but the first few cases were accessed more 
sporadically. This method of sampling is not as robust as other methods, which necessarily 
introduces a potential for selection bias. 
5.3.2   Frequent delays of elective patients 
There are two Obstetric theatres available at CHBH. Emergency caesarean sections take 
precedence over elective cases. Patients are frequently repeatedly delayed and postponed. 
These patients also experience prolonged episodes of unnecessary starvation 
preoperatively. Anxiety is thought to decrease pain sensitivity, decrease discriminability 
between sensation and pain and increase the response in reporting pain 
84
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This repeated cancellation and delay may have led to increased patient anxiety, which may 
affect the results obtained.  However, this should have affected both groups equally but 
may have been a confounding variable, as we did not record or take into account how long 
patients waited before coming to theatre, the number of times that the patients were 
cancelled or postponed and for how many hours the patients where needlessly starved  
preoperatively. 
5.3.3   Accuracy of anatomical landmarks 
Spinal anaesthetics were given at what was clinically assessed to be the L4/L5 interspace. 
The level of injection may have varied between patients due to errors in clinical 
examination, anatomical and physical variations amongst patients. This is a worldwide, 
recognised inaccuracy. Kooger et al. have postulated  that a higher level of injection may 
lead to a shorter duration of anaesthesia due to increased elimination of local anaesthesia 
from the subarachnoid space due to an increased surface area available for diffusion and 
vascular absorption of  the drugs 
148
. 
  
Karim et al. have however shown that injection at L2/L3, L3/L4 or L4/L5 did not 
significantly alter the overall analgesia achieved, but resulted in a significantly faster onset 
of analgesia 
149
.  An attempt was made to minimise this effect by having the researcher 
witness or perform each spinal injection. 
5.3.4   Surgeon variations 
caesarean sections were performed using a standardised lower segment uterine incision via 
Pfannenstiel skin incision, but were performed by a multitude of different surgeons with 
differing levels of experience, which resulted in different surgical durations, different 
techniques involving exteriorisation of the uterus and differing amounts of blood loss. 
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By limiting the duration of data collection to a single obstetric specialist trainee rotation, 
we were able to limit the number of surgeons who performed the caesarean sections. 
5.3.5   Contextuality 
This study was done in the context of patients presenting for elective caesarean section at   
(CHBH). CHBH is a tertiary institute that serves the Soweto area but is also a referral 
hospital for hospitals in the North West province as well as hospitals in the greater 
Johannesburg and Alberton areas.  
Many difficulties are experienced with the referral system from other level 1 and 2 
institutes and patients, sometimes even from other provinces, may present to the hospital 
without appropriate referral. Elective patients are, however, carefully selected and usually 
followed up at the hospital‟s antenatal clinic which may limit this influence. Generalisation 
to other populations may be limited. 
5.3.6   Accuracy of data collected 
A large amount of data was collected from the patients‟ antenatal cards and files. There are 
inherent problems with the retrospective nature of data collection. The accuracy of data 
entered in these records often relies on the individual completing the records. Weights and 
CD4 counts recorded were those most recently entered in the records and may not have 
accurately reflected the actual weights and CD4 counts at the time of caesarean section.  
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5.4   Discussion with regards to the power of this study 
The sample size was originally calculated assuming that a difference of 20 minutes existed 
between these patients, with a standard deviation of 35 and a power of 85%, with the 
significance level set at p <0.05. Once the study was completed it was found that only a 3 
minute difference existed between these groups and that this difference was found to be 
statistically insignificant. The power of the study was recalculated assuming a 3 minute 
difference and was determined to be only 6.74 %. Repeated calculations were done and  it 
was determined that to be able to prove that a statistically significant difference in duration 
of analgesia between HIV positive and  HIV negative patients exists (assuming a 
difference of  3 minutes with a 80% power and standard deviation of 42) we would have 
needed 3078 patients. However, if such a larger sample size is needed then perhaps HIV 
status may not have an effect. Therefore, if the difference of 3 minutes had been a 
clinically relevant time period, this study would have been underpowered. This study was 
adequately powered to determine whether a difference of 20 minutes existed, which is a 
much more useful and clinically relevant time period.  
5.5   Discussion with regards to the distribution and statistical tests used to analyse 
the data 
The data collected was analysed by a Shapiro Wilk test and was found to have a non-
normal distribution. It was therefore decided to analyse the data utilising non-parametric 
test, namely the Kruskal Wallis test and Mann Whitney U test depending on the number of 
variables to be compared. 
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5.5.1  Discussion with regards to non-normality of data 
There are six frequently quoted reasons for non-normality of data which may pertain to the 
data collection for this research
151
: 
5.5.1.1  Extreme Values 
Too many extreme values in a data set will result in a skewed distribution. Normality of 
data can be achieved by cleaning the data. This involves determining measurement errors, 
data-entry errors and outliers, and removing them from the data for valid reasons
151
. The 
severity of pain need for analgesia is such a subjective individual concept that this may 
have resulted in outliers which if removed may have resulted in a normal distribution. 
5.5.1.2   Overlap of Two or More Processes 
Data may not be normally distributed because it actually comes from more than one 
process, operator or shift, or from a process that frequently shifts
151
. This may have 
occurred during our study due to the convenience sampling. 
5.5.1.3   Insufficient Data Discrimination 
Round-off errors or measurement devices with poor resolution can make truly continuous 
and normally distributed data look discrete and not normal
151
. This may have occurred due 
to inherent problems with the visual analogue scale but also because patients were not 
continuously monitored postoperatively but were followed up 5 to 15 minute intervals. 
      5.5.1.4   Values Close to Zero or a Natural Limit 
If a process has many values close to zero or a natural limit, the data distribution will skew 
to the right or left
151
.  
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This may be the case in our research project as the drugs used in spinal anaesthetics  have 
specified durations of onset, effect, and half-lives even those these values may be affected 
by individual physiological parameters such as drug sensitivity, number of receptors 
available, metabolism and excretion. 
        5.5.1.5   Data Follows a Different Distribution 
There are many data types that follow a non-normal distribution by nature. Examples 
include
 
log-normal distribution, found with length data such as heights. The data that was 
collected for this study was of this nature. 
5.5.2 Discussion pertaining to the tests used. 
The Mann-Whitney U test is the alternative test to the t-test. The Mann-Whitney U test is a 
non-parametric test that is used to compare two population means that come from the same 
population. Mann-Whitney U test is also used to test whether two population means are 
equal or not. 
152-156
. The Mann-Whitney U test is a non parametric test; hence it does not 
assume any assumptions related to the distribution. There are, however, some assumptions 
that are assumed in Mann-Whitney U test 
152-156
.  
The following are the assumptions for Mann-Whitney U Test
152-156
: 
1. Mann-Whitney U test assumes that the sample drawn from the population is random. 
2. In Mann-Whitney U test, Independence within the samples and mutual independence is 
assumed. 
3. Ordinal measurement scale is assumed in Mann-Whitney U test. 
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The Kruskal-Wallis one-way analysis of variance by ranks is a non-parametric method for 
testing equality of population medians among groups. Intuitively, it is identical to a one-
way analysis of variance with the data replaced by their ranks. It is an extension of the 
Mann-Whitney U test utilised to analyses data from 3 or more groups
152-155 157.  
The sample sizes in the Kruskal-Wallis test should be as equal as possible, but some 
differences are allowed. The Kruskal-Wallis test also has one limitation. If the researcher 
does not find a significant difference in his data while conducting the Kruskal-Wallis test, 
then he cannot say that the samples are the same
152-155 157
.  
Nonparametric test have both advantages and disadvantages. 
Advantages of nonparametric procedures are:  
(1) Nonparametric test make less stringent demands of the data. For standard parametric 
procedures to be valid, certain underlying conditions or assumptions must be met, 
particularly for smaller sample sizes 
152-155
.  
(2) Nonparametric procedures can sometimes be used to get a quick answer with little 
calculation
152-155
.  
 (3) Nonparametric methods provide an air of objectivity when there is no reliable 
(universally recognized) underlying scale for the original data and there is some concern 
that the results of standard parametric techniques would be criticized for their dependence 
on an artificial metric. For example, patients might be asked whether they feel extremely 
uncomfortable / uncomfortable / neutral / comfortable / very comfortable 
152-155
.   
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(4) Sometimes the data does not constitute a random sample from a larger population.  
Standard parametric techniques based on sampling from larger populations are no longer 
appropriate. Because there are no larger populations, there are no population parameters to 
estimate. Nevertheless, certain kinds of nonparametric procedures can be applied to such 
data by using randomization models
152-155
.  
Disadvantages of nonparametric procedures are:  
The major disadvantage of nonparametric techniques is that there are no parameters to 
describe and it becomes more difficult to make quantitative statements about the actual 
difference between populations. (For example, when the sign test says two treatments are 
different, there is no confidence interval and the test doesn't say by how much the 
treatments differ.) However, it is sometimes possible with the right software to compute 
estimates (and even confidence intervals) for medians, differences between medians. 
However, the calculations are often tedious and a computer and specialised statistical 
software is required
152-155
.  
The second disadvantage is that nonparametric procedures discard information. Ranks 
preserve information about the order of the data but discard the actual values. Because 
information is discarded, nonparametric procedures can never be as powerful (able to 
detect existing differences) or robust as their parametric counterparts when parametric tests 
can be used
152-155
.  
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5.6   Further research 
This research project serves to highlight numerous areas where further research may occur 
with regards to postoperative pain management and HIV. This project also highlights the 
need for further research into the adequacy of referral of HIV-positive parturients from 
antenatal clinics to specialised antenatal HIV clinics at CHBH. 
The fact that this study highlights the limited post-operative analgesia achieved from spinal 
anaesthesia, may prompt others into studying the adequacy of post-operative analgesia and 
patient satisfaction at CHBH, as well as prompting studies into the improvement of these 
services.             
The difficulties encountered during data collection, and the observation that elective cases 
are frequently repeatedly postponed, may prompt further research to examine the actual 
frequency of postponement and delay of elective caesarean sections, the cost of such delay, 
the possible complications of such deferments and assessment of patient satisfaction and 
anxiety scores in these patients pre-operatively. 
In Chapter five we have discussed the results of the study as pertaining to primary and 
secondary objectives. Chapter five has also included a discussion of the study in terms of 
potential limitations of the study, implications for clinical practice and further research. 
The discussion has included an interpretation of the results of the study, and the issues 
raised by the results and tests utilised to analyse the research data. 
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CHAPTER 6 – SUMMARY AND CONCLUSIONS 
Chapter six will include a summary of the study, and conclusions drawn from the study. 
6.1   Summary 
In the previous chapters the results of the study were discussed. The null hypothesis was 
accepted, as HIV status was found to have no significant effect on duration of analgesia. 
The addition of fentanyl to the intrathecal injection was shown to cause significant 
prolongation of the duration of analgesia. The secondary objectives (CD4 count, 
antiretroviral therapy, height, level of education and ethnicity) were found to have no 
significant effect on the duration of analgesia obtained from intrathecal injection. It was 
deemed that the power of the study was actually insufficient and that this study should 
perhaps be viewed as a pilot study, and that further study with a much larger sample is 
necessary to definitively prove the effect of HIV on the duration of analgesia.  
6.2   Conclusions 
The addition of 20 ug fentanyl to hyperbaric bupivacaine significantly prolongs the 
duration of analgesia obtained from intrathecal injection but provides a limited duration of 
postoperative analgesia and thus plays a limited part in post-operative pain management.  
Spinal anaesthesia containing bupivacaine and fentanyl should preferentially be used to in 
our hospital setting as provision of postoperative analgesia is often delayed and there is a 
large population at risk for the development of chronic pain syndromes.   
HIV infection itself has no effect on the duration of analgesia obtained from intrathecal 
injection of bupivacaine alone or in combination with fentanyl and therefore spinal 
anaesthesia may be the most appropriate method of administering analgesia 
intraoperatively to HIV positive patients who do not meet other exclusionary criteria.  
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Interesting questions have been raised by this project, and the potential for further research 
into these areas has been discussed 
The results of this study have provided useful information which can be directly applied in 
the clinical setting, hopefully improving the care given to parturients presenting for 
caesarean section at CHBH in the future.  
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Appendix D  Patient information sheet 
Good morning, my name is Dr Janine Wagner. I am a doctor in the Department of 
Anaesthesia in this hospital. I am conducting a study and would like to include you in it. 
 
You have been identified by your obstetric doctor as needing a caesarean section under 
spinal anaesthesia to deliver your baby. We want to make sure that you are pain free during 
your operation and afterwards. 
 
In South Africa many people are HIV-positive. These patients may suffer from chronic 
pain, have changes in their nerves and they may take medication that may interfere with 
the medicine we use in the spinal injection. There are many safe medicines to use for 
spinal anaesthesia we want to look at two routinely used combinations and see if the pain 
relief that they give is the same for all patients.  
 
If you agree to participate, we will collect some information from you file and antenatal 
green card including your HIV status. This will all be kept confidential. 
 
We will inject one of two combinations of drugs used for spinal anaesthesia and see how 
much time passes before you need another pain relief medication. Both combinations are 
safe and effective and are often used for patients having caesarean sections. 
 
We will need to visit you every 30 minutes until the effects of the medicine have worn off. 
 
 If at any time you have pain we will provide you with medication to stop the pain  
 
Your name and hospital number will not be part of the information collected. There will be 
no way for anyone not involved in the study to know that you have participated or hat 
information we have collected. All information will be stored according to a secret code 
system. Keeping your information confidential is of utmost importance to us and your 
participation in this study will not influence the care you will receive while you are in 
hospital or afterwards. 
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Participating in this study is entirely voluntary. If you decide to participate in the study, but 
change your mind at a later stage, we will remove all your information from the study and 
this will not change the care you receive. 
 
Before you decide whether you will participate or not, do you have any questions? 
If you want to contact me at a later stage about anything you are not sure of regarding the 
study, I am available at any time at 082 933 7194. 
 
Thank You 
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Appendix E  Informed consent form 
 
 
I, _____________________________________________, agree to participate in the study 
that Dr Wagner has explained to me. 
 
I understand that some information about me will be collected from my file and antenatal 
card (HIV status, age, weight, parity, gravidity, surgical and anaesthetic history, history of 
drugs administered prior to, during theatre time and thereafter and duration of pain relief).  
 
I understand that all my information will be given a special code so that no one will be able 
to trace it back to me. 
 
 I understand that my name and hospital number will be kept separate from my 
information, and will be locked away. 
 
I understand that my participation is entirely voluntary and that I can withdraw from the 
study at any time. 
 
Signed at ___________________________ on ____________________________ 
 
 
 
 
Signature 
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Appendix F  Data collection sheet 
Patient Information: 
Patient study number   
Age   
Weight   
Height   
 
Labouring: Yes/No  
Duration of labour: ________________ 
HIV status: positive/negative 
CD 4 count:_______________________ 
 
Anaesthetic Information:  
Time of administration of spinal anaesthetic   
Syringe code   
 
Post operative monitoring: 
Results table:  
Time 0h30 1h00 1h30 2h00 2h30 3h00 
VAS Score             
Analgesic 
requested 
(Y/N)             
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Time 3h30 4h00 4h30 5h00 5h30 6h00 
VAS Score             
Analgesic 
requested 
(Y/N)             
 
Time at which analgesic given: __________________________________________ 
 
 
 
 
 
 
 
